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Sixty-five mildly to moderately mentally retarded 
adult patients from institutional and community placements 
in Louisiana and Texas, with a diagnosis of schizophrenia, 
depression, or no psychopathology were recruited. The 
primary goal was to establish the validity of the 
schizophrenia subscale of the PIMRA for diagnosing 
schizophrenia among mentally retarded individuals. The 
same methods utilized to determine the validity of the 
schizophrenia subscale were also used to replicate the 
validation of the depression subscale of the PIMRA. In 
addition, the extent to which other PIMRA subscale scores 
aid in diagnosis was investigated. Assessment measures 
included the informant version of the PIMRA, DSM-III-R 
checklists for schizophrenia and depression, and a drug 
response rating. Univariate and multivariate analyses were 
conducted as well as interrater reliability on all 
measures. Some support for the validity of the 
schizophrenia subscale of the PIMRA was provided. Support 
was more strongly indicated, however, for the affective 
disorder subscale of this measure. Combinations of 
subscales improved prediction of group membership. Issues 
such as the impact of reliability and the small sample 
size's effect on results were discussed. Implications of 




Recently professional interest has increased in dual 
diagnosis (i.e., the coexistence of mental retardation and 
mental illness). Specifically, researchers have been 
interested in the frequency and types of emotional 
disorders in mentally retarded persons as well as effective 
interventions for managing these coexisting conditions 
(Menolascino, 19 83). In addition, many issues have been 
hotly debated regarding emotional disturbance of mentally 
retarded persons. These issues pertain to questions such 
as whether mentally retarded persons are at greater risk 
for emotional disturbance or whether the various 
psychiatric syndromes are distributed among mentally 
retarded individuals as they are in the general population. 
Also at issue are the potential causes of mental illness in 
mentally retarded persons and the best methods for 
assessing and treating mental illness in this population 
(Lewis & MacLean, 1982). Given the large number of topics 
to be resolved and the fact that many assumptions have 
largely gone unchallenged (e.g., assumed similarity in 
psychiatric symptomatology between mentally retarded 
persons and persons of normal intelligence, assumed 
appropriateness of using the same diagnostic methods 
utilized with nonretarded persons with mentally retarded 
persons), methodologically sound investigations must be 
conducted. Such research can possibly provide an empirical
basis for more adequate services for emotionally disturbed 
mentally retarded individuals. In addition, dual diagnosis 
is important for investigation since severe psychopathology 
and maladaptive behaviors are among the factors most 
commonly precipitating hospital placement of mentally 
retarded people (Ballinger, Ballinger, Reid, & McQueen, 
1991). Better understanding of the cause, course, and 
treatment of such factors among mentally retarded persons 
might help in reducing such hospital admissions.
Despite the interest and realization of the 
significance of emotional disturbance in mentally retarded 
persons, the problem has been largely neglected in 
practice. Much of the available literature is anecdotal 
(Menolascino, 1970). The purpose of this study is to focus 
on one area of neglect, the assessment of dually diagnosed 
individuals. The main impetus of this study was to 
validate the schizophrenia subscale of the Psychopathology 
Instrument for Mentally Retarded Adults (PIMRA; Matson, 
Kazdin, & Senatore, 19 84) , a general measure of 
psychopathology in mentally retarded individuals.
The measures typically utilized to assess mental 
illness in mentally retarded people have not been 
specifically devised or adequately validated for use with 
this population (e.g., Ballinger, Armstrong, Presly, &
Reid, 1975; Fraser, Leudar, Gray, & Campbell, 1986). 
Validation studies involving the assessment measures and
populations of interest are necessary before an accurate 
interpretation of the findings can be obtained. Moreover, 
validation studies are necessary in an area such as dual 
diagnosis where similar symptoms may result from a variety 
of different causes and where differentiation between 
disorders (e.g., mental retardation, schizophrenia, 
depression) has traditionally been difficult.
Some validation research has been conducted with the 
PIMRA. To date, however, only one of eight PIMRA subscales 
(i.e., depression subscale) has been validated for 
assessing mental illness in the mentally retarded 
population (Kazdin et a l ., 1983). In that no other 
assessment measure exists for assessing schizophrenia in 
mentally retarded individuals, it is important that the 
schizophrenia subscale of the PIMRA also be validated for 
diagnosing schizophrenia in mentally retarded persons.
The primary hypothesis of the present study was that 
schizophrenic individuals would have the same diagnosis on 
the PIMRA. In addition, a replication of the validation of 
the depression subscale of the PIMRA was derived from 
comparison data. Another goal of the study was to address 
whether some combination of PIMRA subscale -scores was more 
predictive of a diagnosis of schizophrenia than utilizing a 
single subscale score. In addition, whether individuals' 
responses to medication differed as a function of the 
symptomatic nature of psychopathology was investigated.
However, before further detailing the objectives and 
procedures of the present study, various issues regarding 
mental retardation, schizophrenia, and dual diagnosis in 
general and the PIMRA in particular will be discussed to 
provide a basis for the present research.
Review of the Literature 
Mental Retardation 
Historical Views of Mental Retardation
Prior to the 1800's, the dominant view was that 
mental retardation resulted from supernatural causes 
(Menolascino, 1983). However, a variety of causes were 
believed to exist, rendering mental retardation 
"untreatable" (Scheerenberger, 1983). Therefore, despite 
the fact that mental retardation was a well recognized 
problem, little interest among professionals resulted and 
discussions of mental retardation were largely excluded 
from the medical writings of the period (Menolascino, 1983; 
Scheerenberger, 1983) . In addition, infanticide and 
neglect of these individuals was common, as was housing in 
inadequate residential facilities (Scheerenberger, 1983).
With the dawn of the 19th century came increased 
interest in mental retardation. Itard (1832), a French 
psychiatrist, reported a structured approach to educating a 
mentally retarded boy. His work, along with the rise of 
medicine, increased social provision and urbanization, and 
problems with community care, sparked scientific and 
professional interest in mental retardation. For instance, 
many schools and residential centers for mentally retarded 
persons were subsequently established as well as the 
American Association on Mental Deficiency. . The common 
belief was that intellectual faculties which never
sufficiently developed could be improved through proper 
care, education, and training (Menolascino, 19 83; 
Scheerenberger, 1983). The dawn of the 19th century also 
saw a growing interest in dual diagnosis, especially 
schizophrenia in mentally retarded persons. Kraeplin 
(1896, 1902) concluded that approximately 7% of what he 
termed dementia praecox cases developed from mental 
retardation. He also said that certain forms of mental 
retardation having mannerisms and stereotypies might 
actually be early cases of dementia praecox. He coined the 
term "Pfropfschizophrenie" to indicate a schizophrenic 
psychosis of early onset. Later, Kraeplin modified his 
views, proposing that the rhythmic movements seen in some 
mentally retarded individuals did not necessarily signify 
dementia praecox (Reid, 1972). The term 
"pfropfschizophrenie" has since come to mean different 
things to different researchers (Reid, 1989). Luther 
(cited in Reid, 1972) determined that pfropfschizophrenia 
was really a chance combination of schizophrenia and mental 
retardation. Eventually, Brugger (cited in Reid, 1989), 
who agreed with this view, proposed that the term be 
dropped all together. The issue has been widely debated, 
but Brugger's opinion has essentially prevailed (Reid,
1972, 1989) . Further, the debate may be considered 
constructive in that it led to the identification of the
syndrome of early infantile autism (Kanner, 1943; Reid, 
1989) .
Unfortunately, by the end of the 19th century, 
professionals were adhering to the belief that mental 
retardation was caused by a "brain impairment". Such 
"defects" were believed to lead to a distinct limitation of 
the individual's learning or adaptive abilities.
Therefore, treatment was viewed as insufficient to improve 
these skills. The role of the mental health worker became 
one of custodial gatekeeper rather than promoter of active 
therapeutic intervention (Menolascino, 1983).
Though several eugenicists (i.e., individuals 
advocating for the improvement of a race through the 
control of hereditary factors; Webster, 1977) recanted 
their positions by the beginning of the 20th century, 
interest and benevolence towards mentally retarded persons 
continued to wane. Binet introduced a test in 1908 
primarily for determining children's qualifications for 
special education services. However, the Binet test and 
its subsequent modifications were utilized to the exclusion 
of other techniques and led to the diagnosis of many 
mentally retarded individuals. These individuals were 
viewed as potential social problems and were considered 
dangerous to society. Therefore, by the 1920's and as the 
eugenics movement persisted, more and larger institutions 
were constructed and laws prohibiting marriage and
requiring sterilization of the mentally retarded were 
instituted. Interest and benevolence towards mentally 
retarded individuals progressively deteriorated from the 
1920's to the 1960's (Menolascino, 1983).
Renewed interest in mentally retarded people began in 
the 1960's. Researchers during this period delineated the 
operational definition of mental illness, the similarities 
and differences between mentally retarded and mentally ill 
persons, the determinants of mental retardation, and the 
adjustment potential of mentally retarded individuals. As 
a result, professional interest has increased regarding 
dual diagnosis (coexistence of mental retardation and 
mental illness; Menolascino, 1983).
Psychopathology in the Mentally Retarded
Mentally retarded individuals are more prone to 
develop mental illness than the general population (Lewis & 
MacLean, 1982). In the classic Isle of Wight studies, 
researchers found that the rate of emotional disturbance in 
their mentally retarded sample was five to six times 
greater than that found in the general population (Rutter, 
1971; Rutter, Tizard, & Whitmore, 1970; Rutter, Tizard, 
Yule, Graham, & Whitmore, 1976). Though the study was 
conducted with children, the results may also apply to 
adults (Costello, 1982).
The level of mental retardation has been suggested as 
a possible influence on vulnerability towards mental
illness. Each level of mental retardation is associated 
with unique stressors which may be caused by internal or 
external factors, limit the individual's ability to master 
and control his/her environment, and contribute to the 
expression of a mental illness (Grossman, 19 83; 
Menolascino, 1989). For instance, severely mentally 
retarded individuals are affected by significant central 
nervous system impairment as well as severe language delay 
which might predispose the individuals to behave more 
primitively and make diagnoses by professionals (e.g., of 
psychoses which often rely on verbal self-report) 
difficult. Mildly mentally retarded individuals, 
conversely, are capable of some degree of insight as to 
their limitations and frustration regarding the inability 
to reach others' expectations (Menolascino, 1983).
However, according to Edgerton (19 85), these individuals 
are also often capable of compensating for their deficits 
and attempt to present themselves as competent to others.
Additional factors affecting the prevalence of 
emotional disturbance among mentally retarded persons 
include sociocultural factors (e.g., parental attitudes, 
child-rearing practices, family psychopathology, cultural 
practices, stigmatization, victimization, social 
isolation), social environmental characteristics (e.g., 
socioeconomic status), and physiological and genetic 
variables (Lewis & MacLean, 19 82). Furthermore, although
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mentally retarded persons residing in the community may 
exhibit poor social skills, institutionalized mentally 
retarded individuals may exhibit a greater amount of 
aberrant behavior than those residing in community 
placements (Eyman & Call, 1977).
It is generally agreed that the full range of 
psychiatric disorders are represented within the mentally 
retarded population (Rutter, 1977). For instance, a study 
by Eaton and Menolascino (1982) investigated the frequency 
of mental illness in a community-based population of 
mentally retarded individuals and found that schizophrenia, 
personality disorder, adjustment disorder, and organic 
brain syndrome were most frequent in the population 
studied. The neuroses were underrepresented in this 
sample. However, some researchers have suggested a higher 
incidence of some disorders (Rutter, 1977). For instance, 
Rutter and Lockyer (1967) found a higher incidence of 
autism in their mentally retarded sample and Pond (1961) 
found an increased prevalence of hyperactivity in the 
mentally retarded persons studied. However, not only are 
some disorders less prevalent, but qualitative differences 
were also identified. Bartak and Rutter (1976), in a 
comparison of mentally retarded and nonretarded autistic 
children, determined that low emotionality, deviant social 
responses, insistence on sameness, and attachments to 
objects were more common in mentally retarded persons
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whereas pronominal reversals, sensitivity to noise, and 
ritualistic behavior were more common in the nonretarded 
group.
In sum, the usual factors predisposing those in the 
general population to develop mental illness are often 
exacerbated with mentally retarded individuals. This 
situation occurs because of increased risk associated with 
the level of mental retardation as well as the availability 
of appropriate supports and services and a host of other 
environmental and constitutional factors. There is still 
some disagreement as to whether mental illness in mentally 
retarded persons is quantitatively or qualitatively 
different for the general population (Eaton & Menolascino, 
1982) .
Definitions of Mental Retardation
Various systems of classification have historically 
been used in defining mental retardation. The systems 
used most widely in the United States, however, are those 
proposed by the American Association on Mental Retardation 
(AAMD) and the American Psychiatric Association (1987; 
i.e., Diagnostic and Statistical Manual-III-Revised; 
DSM-III-R).
The AAMD classification system is most popular and 
bases classification on satisfaction of three criteria.
The first requirement is that mental retardation be present 
before 18 years of age. Second, the individual must score
two or more standard deviations below the mean on an 
individually administered intelligence test. Third, the 
individual must exhibit adaptive behavior deficits typical 
of mentally retarded persons. All three criteria must be 
satisfied for an individual to be classified mentally 
retarded. Though some feel the classification of mentally 
retarded individuals should be based solely on scores from 
standardized intelligence tests, the AAMD classification 
system was developed to emphasize adaptive behavior in 
classification (Matson & Frame, 1985; Zigler, Balia,
Hodapp, 1984).
The DSM-III-R (APA, 1987) classification system is 
based on AAMD criteria. However, unlike the AAMD system, 
DSM-III-R accounts for the standard error of measurement in 
diagnosing mental retardation. As an example, although an 
individual may score just within the mild retardation range 
of intellectual functioning on a standardized intelligence 
test, scores indicating moderate to severe deficits in 
adaptive behavior may qualify the individual as more 
severely mentally retarded. Likewise, an individual whose 
adaptive behavior scores are just within the mild mental 
retardation range may potentially be classified as more 
severely mentally retarded on the basis of low standardized 
intelligence scores.
Several factors make mentally retarded individuals 
more prone to mental illness than individuals in the
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general population. Widespread controversy has ensued for 
many years over the incidence and symptomatic progression 
of schizophrenia in mentally retarded persons in 
particular. Therefore, the following sections will address 
this form of mental illness in general as well as how it 
applies to mental retardation.
Schizophrenia 
Definitions of Schizophrenia
Researchers and clinicians alike are perplexed as to 
whether schizophrenia represents a unitary entity. It is 
unclear whether the behaviors typically subsumed under this 
category result from a common core or deficit (Carson,
1984). Some of this confusion has resulted from a failure 
to achieve consensus on how best to conceptualize the 
disorder.
Some investigators ascribe to the medical model of 
schizophrenia. According to this model, it is futile for 
investigators to attempt to describe, define, and 
conceptualize the disorder since it is presumed that an 
invariant set of diagnostic markers infallibly determine 
the diagnosis and all individuals with the -same diagnosis 
will be treated similarly. The fact that we have no such 
set of diagnostic markers is believed to be a resr.lt of 
limitations of our science. Other investigators attempt to 
organize various behaviors into more general symptom 
classes. This latter approach increases the likelihood of
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determining multiple pathways to the development of various 
behaviors or symptoms. However, we have failed to reach 
consensus about which behaviors make up the path most 
likely to lead to schizophrenia (Carson, 1984).
Bleuler (1911, 1950) coined the term "schizophrenia" 
when he determined that Kraeplin's label of "dementia 
praecox" was misleading. His argument was that not all 
individuals exhibited symptoms at an early age and symptoms 
did not always progress into profound cognitive 
deterioration. Bleuler proposed a set of fundamental 
symptoms constituting the classic definition of 
schizophrenia. These symptoms include difficulties with
(1) association (i.e., "looseness" in thought processes),
(2) affectivity (i.e., affect is not appropriate in type 
and/or degree given the situation), (3) ambivalence (i.e., 
contradictory feelings, motives, and/or ideas are 
experienced simultaneously), and (4) autism (i.e., 
loosening of ties to reality). These symptoms were 
believed to be essential to the diagnosis. Therefore, any 
differences in the clinical picture between patients were 
due to variations in the quantity and/or quality of the 
"accessory symptoms". These symptoms included delusions, 
hallucinations, somatic phenomena, catatonic symptoms, and 
disturbances of personhood (Carson, 1984).
Despite Bleuler's efforts to define schizophrenia, it 
became increasingly apparent that reliability of diagnoses
based on Bleuler's criteria was extremely poor. Therefore, 
Schneider (19 59) proposed a diagnostic system with symptoms 
believed to be highly salient and frequent. According to 
this system, several "pathognomonic" signs or first-rank 
symptoms (e.g., hallucinations, delusions, somatic 
symptoms) are considered "accessory" in Bleuler's system. 
Schneider's conceptions led to improved diagnostic 
agreement between clinicians and had a great influence on 
the DSM-III criteria of schizophrenia (Carson, 1984). 
However, several investigations have indicated that the 
criteria proposed by Schneider do not adequately 
discriminate schizophrenia from affective and other 
disorders (e.g., Carpenter, Strauss, & Muleh, 1973; McCabe 
& Stromgren, 1975;, Newmark, Falk, Johns, Boren, &
Forehand, 1976; Wing & Nixon, 1975; World Health 
Organization, 1973).
Other definitions of schizophrenia have been proposed. 
In 1962, Meehl suggested a "schizotypic tetrad" which, like 
Bleuler's definition, emphasized more formal 
characteristics of psychological functioning. The tetrad 
consisted of associational loosening (i.e., cognitive 
slippage), ambivalence, interpersonal aversiveness, and 
anhedonia. This approach has not been well evaluated 
(Carson, 1984). Other criteria include those of Feighner 
and colleagues (Feighner, Robins, Guze, Woodruff, & Munoz, 
1972) and of Spitzer and colleagues (Spitzer, Endicott, &
Robins, 1975), the former being more Bleulerian and the 
latter more Schneiderian in nature. Both sets of criteria 
were very influential in the formulation of the DSM-III 
definition of schizophrenia (Carson, 1984). Others have 
also engaged in efforts towards establishing an agreed upon 
definition of schizophrenia (e.g., Carpenter, Strauss, & 
Bartko, 1973; Carpenter & Strauss, 1979). Perhaps once a 
general definition of schizophrenia has been agreed upon, 
research such as that regarding distinct subtypes of 
schizophrenia (e.g., process vs reactive) will no longer be 
neglected in diagnostic research.
Despite these varied efforts, the DSM-III-R 
constitutes the formal and officially accepted definition 
of schizophrenia. The actual diagnostic criteria according 
to this system is presented in Appendix A. Though the list 
of criteria is comprehensive and represents a mixture of 
Bleulerian and Schneiderian signs, certain limitations 
which were outlined by Carson (1984) in reference to the 
DSM-III (APA, 1980) may apply to this system. First, the 
criteria are not operationally defined and require a fair 
amount of subjective judgments. The criteria are presented 
so as to suggest that any given symptom can have only one 
source even though several of the symptoms 'overlap with 
symptoms of other disorders. Finally, some decision rules 
appear to be arbitrary and a source of confusion (Carson, 
1984). Despite these problems, however, the DSM-III-R
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(like the DSM-III) is a move towards enhancing objectivity 
and reliability in the diagnosis of schizophrenia. 
Epidemiology
Traditionally, variables such as socioeconomic 
status, ethnicity, and geographic migration have been 
researched and believed to affect the incidence and 
prevalence of schizophrenia. A study by Hollingshead and 
Redlich (1958) supported a common belief that a negative 
correlation exists between socioeconomic status and risk of 
schizophrenia. There is disagreement, however, as to 
whether lower-class conditions promote stress that leads to 
a higher rate of decomposition, or if at risk individuals 
tend to drift into the lower socioeconomic levels. In 
addition, not only has the proposed relationship between 
SES and risk of schizophrenia not held in all cases, but 
also the findings have actually been reversed (i.e., more 
schizophrenia in the upper classes). Perhaps SES is not 
the determining variable but rather a variable that 
obscures the variables that actually determine risk 
(Carson, 1984). For instance, lower SES can be associated 
with more stressful living conditions, increased genetic 
risk, and less resourceful socialization processes (e.g., 
less likely to seek services; Kohn, 1973). Studies have 
also been conducted to investigate the effect of ethnicity 
on risk for schizophrenia. Most studies of this type have 
concentrated on the difference between white and black
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individuals (Carson, 1984). Results of these 
investigations indicate that proportionally more blacks 
than whites are diagnosed with schizophrenia (Kramer,
Rosen, & Willis, 1973). However, it has been questioned 
whether these are more a result of prejudices in providing 
health care or assigning diagnoses or do, in fact, 
constitute real differences (Fischer, 1969).
In a review by Torrey (1979), many other studies 
examining prevalence rates of various ethnic groups were 
detailed. Researchers report high prevalence rates for 
some groups and low rates for others. We question the 
generalizability of the proposed 1% incidence rate of 
schizophrenia worldwide (Carson, 1984). In addition, the 
variations from this proposed prevalence rate are 
significant enough that they cannot be sufficiently 
accounted for by genetic or other biological factors. 
Rather, the risk of schizophrenia is undoubtedly affected 
by different cultural factors. However, these specific 
factors have not been identified (Carson, 1984).
Other factors proposed to increase the incidence of 
schizophrenia include significant migration (i.e., overseas 
or intracontinental; Sanua, 1970). The proposed hypotheses 
for this finding conflict and are analogous to those 
proposed for SES (Carson, 1984). Furthermore, studies 
presented in the review by Torrey (1979) suggest that 
schizophrenia may be more prevalent in individuals born in
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certain months of the year. That is, individuals who later 
manifest schizophrenia tend to be born in late winter or 
spring, though this time period varies moderately among 
different parts of the world (Carson, 1984). Among the 
hypotheses for this effect is that an environmental 
pathogen with the potential to affect fetal development 
during particular phases of pregnancy may be more prevalent 
at certain times of the year (Carson, 1984).
In sum, the hypotheses are many but the facts or 
proven explanations are few. More research is definitely 
in order to sort out the primary schizophrenic risk factors 
and to develop the explanations for these factors.
Etiology
As with other areas of inquiry within the realm of 
schizophrenic research, controversy and confusion has 
dominated. A variety of etiological theories have been 
proposed, targeting factors such as genetics, biochemistry, 
high-risk, family and other environmental influences, as 
well as current stress.
The ongoing nature-nurture debate is evident in 
hypotheses regarding the etiology of schizophrenia as it is 
in virtually every other disorder. The prevailing view is 
that both nature and nurture characterize schizophrenia 
(Carson, 19 84). Evidence for the genetic hypothesis has 
been provided by twin and adoption studies.
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Twin studies suffer from the inherent limitation that 
approximately 70% of monozygotic twins share their 
intrauterine environment (i.e., the same chorion in the 
placenta) and dizygotic twins never do. Therefore, any 
pathogenic elements causing specific problems will 
subsequently be viewed as higher concordance for 
monozygotic twins. However, this concordance would not 
support a genetic hypothesis in that the concordance was 
not caused by genetics (Carson, 1984).
In addition, early twin studies (e.g., Kallman, 1946) 
were methodologically flawed and proposed inflated 
concordance estimates. More recent methodologically sound 
studies (e.g., Gottesman & Shields, 1972) have proposed 
concordance rates of approximately 50%. Although this rate 
is three times that in dizygotic twins and far exceeds the 
expectancy in the general population, it also indicates 
that heredity is not the sole etiological factor in the 
development of schizophrenia (Gottesman, 1978).
Moreover, the fact that twins almost always share the 
same environment has been suggested as a possible reason 
for the discrepancy in rates between monozygotic twins and 
dyzygotic twins or nontwins. In a study involving 28 twin 
pairs, concordance rates were not found to differ between 
monozygotic twins reared apart versus those reared together 
(Gottesman, 1978). However, this data is based on a small 
sample and requires replication. Another study worthy of
mention is that of the Genain quadruplets (Rosenthal,
1963). These monozygotic sisters all developed some form 
of schizophrenia prior to age 25. Apparently, there was 
some genealogical evidence of genetic abnormalities. 
However, there was also evidence that the whole family 
context was pathological and the severity and 
intractableness of the twins' disorders appeared to be 
significantly correlated with the degree to which 
environment influenced their psychopathology (Carson,
1984). Nonetheless, the twin studies appear to provide 
support for the role of heredity in the development of 
schizophrenia. However, these studies also suggest that 
this genetic influence is relatively small and that other 
factors may also play a role in the disorder.
Adoption studies involve an early-life separation from 
biological relatives and are an attempt at separating the 
influences of heredity and environment. Such studies have 
provided the strongest evidence to date for the role of 
genetics in the etiology of schizophrenia (Carson, 1984).
An example of the findings of this research is a study 
mentioned in a review by Kety and colleagues (Kety, 
Rosenthal, Wender, Schulsinger, & Jacobsen,- 1978) . In this 
study, 21.4% of the biological relatives of adopted 
individuals who became schizophrenic were diagnosed with 
some form of "schizophrenic spectrum" disorder whereas only 
10.9% of the control adoptees' biological relatives were
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given such diagnoses. Furthermore, the rates of disorder 
in the adoptive relatives of each group were 5.4% and 7.7%, 
respectively.
However, Sarbin and Mancuso (1980) have challenged 
findings from adoption studies like these. Among other 
criticisms, they point out that the adopted children 
studied tended to have low rates of schizophrenia while the 
relatives had high rates. In addition, they contend that 
children living in such negative environments so as to be 
removed from their homes might be expected to develop 
psychopathology. Kety and colleagues (1978) also explain 
that adoption studies have supported the role of fathers in 
transmitting vulnerability to schizophrenic illness. This 
finding nullifies the suggestion that genetic factors are 
due entirely to intrauterine defects of mothers.
Some influence of genetics in the development of 
schizophrenia are evident. However, as noted with the twin 
research, the results also indicate that genetics are not 
the sole explanatory factor (e.g., Carson, 1984).
Several theories have been proposed focusing on 
biochemical factors as implicated in the development of 
schizophrenia. One hypothesis, the transmethylation 
hypothesis, resulted from the observation that the 
ingestion of various drugs resulted in symptomatology 
reminiscent of, though not identical to, schizophrenia. 
Apparently, many of these drugs are chemically related to
neurotransmitters mediating synaptic transmission in the 
brain. According to the hypothesis, methylation of 
derivatives of these neurotransmitters accumulate in the 
brain and induce psychotic symptomatology (Barchas,
Elliott, & Berger, 1.978) . However, researchers have failed 
to identify the specific compound distinctively associated 
with schizophrenia. The failure to confirm this hypothesis 
has led researchers to investigate other possibilities 
(Carson, 1984) .
Concurrent with the waning interest in the 
transmethylation hypothesis was the increasing interest in 
the role of dopamine in the development of schizophrenia. 
This hypothesis resulted from the consideration that the 
neuroleptic drugs, used to moderate schizophrenic symptoms, 
are known to block the neuronal receptor for dopamine. In 
addition, the potency of these drugs is highly correlated 
with the extent to which this blockade is accomplished.
The resulting implication is that schizophrenia results 
from an excess of dopamine in the brain (Carson, 19 84). 
Other evidence in support of this hypothesis includes the 
fact that amphetamines and amphetamine-like substances 
produce psychotic symptoms and exacerbate symptoms of 
schizophrenics (Janowsky, El-Yousef, Davis,- & Sekerke,
1973). What is interesting is that these substances are 
known to release dopamine from storage sites in the brain 
(Carlsson, 1970) . Moreover, L-Dopa, a precursor of
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dopamine and known to increase it, can produce 
schizophrenic symptoms in some individuals (Murphy, 19 73) 
and worsen symptoms in schizophrenics (Meltzer, 1979) .
Despite this positive evidence, there are 
contraindications to the dopamine hypothesis. For 
instance, even heavy doses of neuroleptics suppress rather 
than cure schizophrenic symptoms. In addition, the 
neuroleptics have "antipsychotic" effects when administered 
to individuals with other disorders (Carson, 19 84). One 
might also expect, if the dopamine hypothesis held firm, 
that there would be an excess of homovanillic acid, a 
metabolite of dopamine, in the cerebrospinal fluid of 
schizophrenic individuals. However, no such excess has 
been discovered (Barchas, et al., 1978). Therefore, 
perhaps schizophrenic individuals have oversensitive 
dopamine receptors or an overabundance of them (Carson, 
1984). Lastly, it has been noted (e.g., Davis, 1978) that 
when neuroleptics are ingested, dopamine receptors are 
rapidly blocked. However, the moderation of symptoms 
occurs gradually. Therefore, perhaps dopamine plays only a 
secondary role in schizophrenia (i.e., exacerbates symptoms 
already present) rather than actually causing the disorder 
(Davis, 1978).
Other biochemical theories have been proposed though 
they lack sufficient evidence to be considered viable 
alternatives at present. For instance, one theory (Stein &
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Wise, 1971) suggests that there is a deficit in 
dopamine-beta-hydroxylase, an enzyme which destroys 
dopamine, leading to an excess of dopamine which is then 
converted into a neurotoxin, 6-hydroxydopamine (Carson, 
1984). However, evidence of such deficits in schizophrenic 
individuals have not yet been found (Meltzer, 1979).
Another theory, the MAO-depletion theory, is based on 
the questionable assumption that platelet levels of 
monoamine accurately reflect the quantity of MAO activity 
occurring in the brain (Meltzer, 1979) . Though one study 
found diminished platelet MAO activity and triggered a fair 
amount of research (Murphy & Wyatt, 19 72), their findings 
remain questionable (Meltzer, 1979).
One final biochemical hypothesis of schizophrenia is 
the viral hypothesis derived from the observation of 
several facts including: (1) catatonia may -be associated
with widespread physical collapse resulting in death; (2) 
obstetrical complications and congenital anomalies are 
common in schizophrenic women and their offspring, 
respectively (McNeil & Kaij, 1978; Rieder, Rosenthal, 
Wender, & Blumenthal, 1975; Sobel, 1961); (3) schizophrenic
persons have a high incidence of abnormal finger, palm, and 
foot prints; (4) they also tend to exhibit abnormal 
capillary formations; (5) neurological "soft signs" and EEG 
abnormalities are common in schizophrenics;' and (6) some 
will evince enlarged ventricle and cortical sulci in the
brain (Golden, Maclnness, Ariel, Ruedrich, Chung-Chou, 
Coffman, Graber, & Bloch, 1982). Other facts consistent 
with such a hypothesis is the fact mentioned previously 
that schizophrenic individuals tend to be born at certain 
times of the year when a virus might be more prevalent. 
Also, the proposal of a slow-acting virus is compatible 
with the typically gradual onset of symptoms and tendency 
for neurological involvement to be concentrated in one area 
(Carson, 1984) .
In sum, biochemical hypotheses in understanding 
schizophrenia have yielded few gains. The typical pattern 
appears to be one of initial excitement, stagnation, and 
then movement to a new hypothesis.
Another approach to understanding schizophrenia has 
been the high-risk strategy. This approach is based on the 
fact that a large proportion of children of schizophrenic 
parents become schizophrenic themselves. Respite the 
intensity to which this hypothesis was pursued, the gains 
have been minimal and it has been difficult to identify 
variables that reliably differentiate between the children 
who become schizophrenic and those who don't. Other 
problems include the difficulty in distinguishing between 
children born to schizophrenic parents who may have the 
genes and the fact that at-risk children may develop a wide 
array of disorders other than schizophrenia (Carson, 1984).
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An applied example of this approach is provided by 
studies by Mednick and colleagues (Mednick, Schulsinger, & 
Schulsinger, 1975; Mednick, Schulsinger, Teasdale, 
Schulsinger, Venables, & Rock, 1978). Factors which 
differentiate schizophrenics from other high-risk subjects 
included: (1) earlier onset of mother's disorder and
hospitalization, (2) more frequent obstetrical 
complications, and (3) more conduct problems reported at 
school. In addition, these investigators discovered that 
the mother's onset of the disorder had an indirect effect 
on the development of schizophrenia in the male offspring 
by increasing the chances of parent-child separation. 
Furthermore, schizophrenia in male offspring appeared to be 
related to an autonomic nervous system anomaly. Given the 
methodological problems of the studies, however, the 
results are questionable (Rieder, 1979).
Other hypotheses for the development of schizophrenia 
have been proposed and the discussion would not be complete 
without a brief mention of them. First, several 
investigators have proposed a direct influence of parent 
characteristics on the development of schizophrenia in 
their offspring. However, the influence may be more 
bidirectional than unidirectional. The more recent trend 
towards longitudinal (versus cross-sectional) research in 
this area may better substantiate these claims (Carson,
1984) .
Other researchers have attempted to identify 
additional environmental variables which differentiate 
schizophrenic individuals from the general population. 
Though it has been difficult to identify such variables 
(e.g., Gottesman & Shields, 1972), it is possible that 
stressful life events may precipitate schizophrenic 
episodes (Dohrenwend & Egri, 1981). Others propose that it 
is not the occurrence of noxious events per se but rather 
the patterns or sequences in which they occur (e.g.,
Carson, 1984). Also, it has been suggested that stressful 
events are not the predisposing factors but the nature of 
the inconsistent and disruptive context in which they occur 
(Anthony, 1978).
According to Zubin and Spring (19 77), however, it is 
an individual's vulnerability to illness that determines 
the effect of stressors on the development of the disorder. 
That is, for highly vulnerable people, even daily stressors 
may be enough to elicit the disorder whereas the less 
vulnerable people will require more traumatic events to 
induce the disorder.
Finally, some research has appeared to indicate that 
some schizophrenia may merely be an individual enacting a 
role to manipulate and control their environment (e.g., 
Braginsky, Braginsky, & Ring, 1969; Drake & Wallach, 19 79). 
A group of studies appear to suggest that schizophrenic 
symptoms appear to fluctuate according to the demand
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characteristics of the interpersonal situation in which 
they're involved (e.g., Levy, 1976; Shimkunas, 1972).
In sum, etiological studies of schizophrenia have 
failed to identify a single agent responsible for the 
development of schizophrenia. There appears to be support 
for genetic, biological, and environmental causes. Further 
research would be warranted before firm conclusions could 
be drawn.
Assessment and Diagnosis of Schizophrenia 
in the Mentally Retarded 
Confusion is inherent in the area of dual diagnosis 
and scant research on measurement has occurred. Problems 
in the assessment and diagnosis of schizophrenia in 
mentally retarded persons are representative of the 
problems inherent in the area of dual diagnosis.
Several major problems exist. Although schizophrenia 
and other forms of psychopathology are generally believed 
to exist in mentally retarded populations, it is often 
difficult in the dually diagnosed patient to differentiate 
whether the psychosis or mental retardation is the primary 
contributing factor to symptomatology (Ballinger et al., 
1991; Lund, 1985). The bizarre speech and behavior that 
emerges in schizophrenic individuals may be wrongly 
attributed to the mental retardation and possibly result in 
delayed or inappropriate treatment (Meadows, Turner, 
Campbell, Lewis, Peveley, & Murray, 1991). Second,
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delusional and hallucinatory material is difficult to 
assess in mentally handicapped due to problems eliciting 
verbal reports of such symptomatology from this population. 
Third, the blunting of affect and schizophrenic withdrawal 
may likewise be difficult to assess unless the clinician is 
familiar with and does not need to rely on the verbal 
report of the patient (Costello, 1982).
However, it is important that we do not ignore this 
area of research in that psychiatric and behavioral 
symptoms are widespread in the mentally retarded population
(Ballinger et al., 1991). In addition, it may be that
schizophrenics with mental retardation present the most 
severe form of psychotic disorder and may be a great source 
of clues regarding etiology (Turner, 1989) . Moreover, it 
is important to critically investigate this area in that 
severe psychopathology (e.g.,' positive symptoms of 
schizophrenia) and behavior disorder (i.e., maladaptive 
behaviors) are significant factors leading to
hospitalization (Ballinger et al., 1991).
Research that has been conducted on dual diagnosis has 
been inadequate and has led to varied results regarding 
assessment and diagnosis (Romanczyk & Kistner, 1982). The 
possible reasons for these difficulties and discrepancies 
include historical biases, vague and diverse diagnostic 
criteria, sampling problems, varied subject populations, 
different and inadequate assessment measures, and differing
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study purposes. These sources of differences and 
discrepancies as well as studies which illustrate them will 
be outlined briefly.
Historical Bases
Historically, both professionals and the lay public 
have tended to equate mental retardation with mental 
illness. The diagnoses of mental retardation and psychosis 
seem to be used in a mutually exclusive manner, prohibiting 
accurate assessments of either population (Romanczyk & 
Kistner, 1982).
The view that mental retardation and mental illness 
are one and the same may serve to bias the .researcher's or 
professional's motivation to advance research in the area 
and ability to identify the disorder if it does exist. 
Typically when assessing dually diagnosed individuals, the 
same assessment tools used to identify mental illness in 
normal intelligence people are utilized or attempts are 
made to avoid the assessment altogether on the basis that 
the available assessment tools are inadequate and may lead 
to mislabelling and disadvantage of the individual 
(Costello, 1982) .
Vague and Diverse Diagnostic Criteria
Another source of difficulties and discrepancies in 
research concerning the assessment and diagnosis of 
mentally retarded schizophrenics is poor reliability of the 
definition of schizophrenia, which varies widely among
professionals and researchers (e.g., they differ according 
to the extent to which they rely on verbal criteria). 
Furthermore, surveys of dually diagnosed patients have 
often been vague in delineating diagnostic criteria 
(Turner, 1989; Wright, 1982). For instance, Wright (1982) 
outlined the areas in which data were collected and used 
for diagnosis but failed to delineate specific criteria 
required for diagnosis. Apparently, he used no formal 
diagnostic system.
However, Hucker, Day, George, and Roth (19 79) 
recognized the controversial nature of the criteria for 
schizophrenia and made a serious attempt at applying 
strictly defined criteria (i.e., modified Feigner et al. 
(1972) criteria) in examining schizophrenia and affective 
psychoses in a mentally handicapped population.
Also, Lund (19 85) investigated the prevalence of 
psychiatric morbidity in mentally retarded adults and 
utilized a more systematic diagnostic approach. That is, 
assessments were conducted utilizing an interview schedule 
supplemented by a list of psychiatric items compiled during 
a pilot study. Furthermore, the author proposed use of 
clearly defined diagnostic groups (e.g., edch group 
satisfies a specific set of criteria for a specific 
disorder) and based diagnoses on the modified Feighner et 
al. (1972) and DSM-III criteria (APA, 1980).
It is important to note that no objective signs and 
symptoms which are relevant to mentally handicapped persons 
with little or no expressive language have been identified 
for schizophrenia as they have with other mental illnesses 
(e.g., Pollitt, 1978; Wright, 1982). Therefore, some 
authors have attempted to apply unmodified standardized 
psychiatric criteria to the mentally handicapped population 
despite debates regarding the suitability of this practice 
(e.g., Ballinger et al., 1991; Russell, 1988).
Sampling Problems
The sampling procedures utilized in research 
involving the assessment and diagnosis of dually diagnosed 
mentally retarded schizophrenics have varied between 
investigations (e.g., deriving sample populations from 
homogeneous or heterogeneous settings), leading to 
discrepant results (Romanczyk & Kistner, 1982). Some 
researchers have drawn their samples from institutions 
(e.g., Ballinger, Armstrong, Presley, & Reid, 1975; 
Ballinger et al., 1991; Linaker, 1991; Wright, 1982). Such 
procedures tend to bias the results in that such samples 
often have a disproportionate number of severely mentally 
retarded cases as well as less severely mentally retarded 
individuals with significant behavior disorders in that 
these are the types of individuals most likely to be 
hospitalized (Saenger, 1960).
Other researchers have used more community-based or 
heterogeneous settings (e.g., Fraser, Leudar, Gray, & 
Campbell, 1986; Gostason, 1985; Lund, 1985). In contrast 
to the institutionalized samples, the community-based 
samples are likely to be composed of individuals with less 
severe levels of mental retardation and behavior problems. 
These are likely to be individuals who have learned to 
adapt well to their environment. Pathology is perhaps more 
difficult to detect in this group. Conversely, studies 
where samples are chosen from both institutions as well as 
the population at large (e.g., individuals living at home 
and working in training centers) would perhaps allow for 
the best cross-section and most representative and accurate 
profile of the dually diagnosed mentally retarded and 
schizophrenic population.
Varied Subject Populations
Another confounding factor in dual diagnosis research 
is that typically both less verbal severely to profoundly 
mentally retarded individuals and more verbal mildly to 
moderately retarded individuals are included in the same 
studies. There are often no attempts at segregating or 
differentially assessing and diagnosing groups based on 
level of mental retardation or level of language 
functioning. For instance, in studies by .Linaker (1991) 
and Wright (1982), approximately 66% and 75% of the subject 
populations, respectively, were functioning in the
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severe/profound range of mental retardation. All subjects 
within each study were submitted to the same assessment and 
diagnostic procedures irrespective of intellectual and 
language abilities.
The results of these studies perhaps underrepresented 
the prevalence of the MR/Schizophrenia diagnosis in that 
the severity of the population would likely have 
invalidated the use of any methods relying on verbal 
communication. Particularly for the more severely mentally 
retarded and less verbal individuals, the diagnostician is 
precluded from using more traditional interview and 
self-report techniques (Lewis & MacLean, 19 82). Rather, 
the diagnostician is forced to utilize direct observations 
and reports of various caregivers. Both have greater 
potential for leading to misdiagnosis due to patient 
reactivity. Moreover, caregiver reports may lead to 
misdiagnosis due to caregiver sensitivity to specific 
behaviors as well as habituation and tolerance due to the 
probable long history of the problems (Costello, 1982;
Lewis & MacLean, 19 82). Therefore, it appears that 
assessment and diagnosis would be most accurately 
accomplished if different diagnostic methods were utilized 
for the more severe and mild mentally retarded populations 
and if both groups were investigated separately.
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Assessment Measures
Various assessment measures have been utilized in 
studies investigating dually diagnosed patients. This 
diversity as well as the fact that many measures have not 
been adequately modified and validated for this population 
has led to discrepant findings and interfered with an 
accurate interpretation of these findings.
Fraser and colleagues (1986) used the Clinical 
Interview Schedule (CIS; Goldberg et al., 1970) as well as 
the Behavior Disturbance Scale (BDS; Leudar, Fraser, & 
Jeeves, 1984) in their assessment of 133 mentally 
handicapped subjects. These scales, used with non-retarded 
populations, were both given without modifications to 
subjects in their study. Therefore, particularly on the 
CIS, in which part of the interview relies on self-report 
data, it is difficult to predict how the scores were 
affected by the severity of the subjects' retardation and 
expressive abilities.
The CIS has also been used in other studies (e.g., 
Ballinger et al., 1975; 1991) though in modified form, 
making it more comprehensible to and useful with the 
mentally handicapped population. However, adequate 
validation studies have not been conducted with this 
modified form. In addition, in that the scale was 
originally developed for use in community surveys, it was
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most probably intended and most well suited to a higher 
functioning population than utilized in these studies.
Other studies (e.g., Linaker, 1991; Lund, 1985) have 
more appropriately used methods specifically designed for 
assessing the mentally retarded population (e.g., MRC-HBC 
schedule, Wing, 1980; PIMRA, Senatore, Matson, & Kazdin,
1985). However, the scales are not specifically designed 
to assess schizophrenia, but rather are designed to assess 
a wide range of psychopathology.
Assessment and diagnosis research conducted in the 
area of the dually diagnosed MR/Schizophrenia population 
has been discrepant in that the aims of the various studies 
differ. In some studies investigators have assessed the 
incidence of mental retardation among schizophrenics rather 
than the incidence of schizophrenia among mentally retarded 
individuals (Romanczyk & Kistner, 1982). Others have 
investigated the prevalence of psychosis as well as a large 
range of psychiatric disorders in the mentally retarded 
population (e.g., Lund, 1985). The form of mental illness 
and the way in which it presents in the mentally retarded 
(e.g., Wright, 1982) as well as the response of dually 
diagnosed mentally retarded schizophrenics .to treatment 
(e.g., Reid, 1972) are still other topics of interest of 
researchers conducting investigations in this field. As a 
result, it is difficult to derive conclusions from these 
studies since the aims are so discrepant (Turner, 19 89).
Meadows et al. (1991) remedied some of the factors
previously outlined which contribute to some of the 
confusion and discrepancies in dual diagnosis research. 
Their study involved a comparison of 25 patients with mild 
mental retardation and schizophrenia and 26 schizophrenic 
patients of at least average intelligence. The goal was to 
address whether the coexistence of mental retardation and 
schizophrenia leads to a clinical picture different than 
that of schizophrenia in the general population.
The authors defined the inclusion criteria for each 
group and a standard set of symptom definitions and formal 
diagnostic criteria were utilized to minimize variability 
in diagnostic procedures. A limited nonhospitalized and 
mildly mentally retarded population was utilized to allow 
for a more practical comparison between mentally retarded 
and nonretarded schizophrenics than if a more severe, 
heterogeneous, and/or nonverbal population was utilized. 
Meadows and colleagues (1991) also conducted a comparison 
study using nonretarded schizophrenics as the control 
group. Control groups are necessary (and have been 
neglected in this area of research) when attempting to draw 
conclusions about group similarities and differences. The 
authors concluded that schizophrenic symptoms are similar 
in form and content between groups, though the timing and 
course of the symptoms may differ.
Although the study advanced previous dual diagnosis 
research by addressing several of the problems inherent 
with dual diagnosis research noted previously (e.g., 
historical biases, vague/diverse diagnostic criteria, 
sampling problems, varied subject populations) and by 
investigating a specific form of psychopathology, the 
authors did leave room for improvement. For example, they 
utilized a measure limited in scope to schizophrenia and 
the affective disorders. In addition, the research 
conducted by Meadows et al. (1991) is the first to use an
unmodified, standardized diagnostic interview to assess 
patients with both mental retardation and schizophrenia 
(i.e., SADS-L; Endicott & Spitzer, 1978). However, 
research into the validation of this approach is needed in 
that the SADS-L was not designed to measure schizophrenia 
in mentally retarded individuals. A variety of measures 
have been utilized in dual diagnosis research, none of 
which have been adequately validated for use with mentally 
retarded schizophrenics. The Meadows et al. (1991) study
is no exception.
Psychopathology Instrument for Mentally Retarded Adults 
(PIMRA; Matson, Kazdin, & Senatore, 1984)
The PIMRA is based on the Diagnostic and Statistical 
Manual, third edition (DSM-III; APA, 1980),. and is the only 
measure specifically developed to assess psychopathology in 
mentally retarded individuals. As such, it was considered
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most appropriate for the present study. The measure was 
developed to aid in (1) treatment planning, (2) evaluating 
effects of treatment, (3) diagnosing mental illness in 
mentally retarded individuals, and (4) training of the 
psychiatric aspects of mental retardation. It is 
considered to be best utilized in the context of a complete 
evaluation and in conjunction with other means of 
collecting diagnostic information.
The PIMRA consists of two structured interviews, a 
self-report and an informant version. It has 8 subscales 
(see Appendix B) and assesses seven forms of 
psychopathology (i.e., schizophrenia, depression, 
psychosexual disorders, adjustment disorder, anxiety, 
somatoform disorders, and personality problems). The 
measure utilizes a yes/no format and consists of seven 
items for each scale (see Appendix B). The "rule of thumb" 
is that at least four of the seven items need to be present 
to make a diagnosis.
Despite the growing interest in dual diagnosis and the 
need for measures adequate for assessing this population, 
the PIMRA has not been sufficiently researched. According 
to the studies that have been conducted to date, however, 
the measure has generally been found to have good internal 
consistency and test-retest reliability (Aman, Watson, 
Singh, 1986; Matson et al., 1984; Senatore, Matson, & 
Kazdin, 1985) though some discrepancy in results does exist
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(e.g., Sturmey & Ley, 1990) . Although the measure was 
found to possess good external validity by Kazdin and 
colleagues (Kazdin, Matson, & Senatore, 1983), other 
validation studies are warranted.
In addition, an attempt to validate the PIMRA for use 
with mentally retarded depressed individuals was conducted 
by Kazdin, Matson, and Senatore (1983). In this study, 110 
subjects from both inpatient and outpatient settings and 
having a primary diagnosis of mental retardation were 
included. One aspect of the study was an investigation of 
the relationship between psychiatric diagnoses and 
scores on various self-report and informant measures. The 
PIMRA depression scale was used for the diagnosis of 
depression to ensure a consistent basis for diagnosis 
across patients and settings and enable the application of 
DSM-III criteria. Scores on the Beck Depression Inventory, 
Zung Depression Scale, and Hamilton Rating "Scale were 
significantly higher for subjects diagnosed with depression 
according to the PIMRA than for those who were not 
diagnosed with depression. These findings provide initial 
support for the validity of the PIMRA depression scale in 
assessing depression in mentally retarded persons.
However, validation of other subscales of the PIMRA also 
need to be conducted to further delineate the utility of 
the PIMRA for diagnosing psychopathology in the mentally 
retarded population. Therefore, the present study was an
attempt to establish the validity of the schizophrenia 
subscale for diagnosing schizophrenia in mentally retarded 
individuals.
The Proposed Study 
The purpose of the present study was three-fold.
First, an effort was made to establish the validity of the 
PIMRA's schizophrenia subscale. More specifically, 
criterion-related validity was investigated with the score 
on the schizophrenia subscale of the PIMRA serving as the 
criterion in predicting group membership.
Criterion-related validity was chosen since, when 
validated, the PIMRA will be utilized to classify or 
diagnose individuals (Matson, 1988). Therefore, it is 
important to establish whether the PIMRA can be used to 
adequately predict. This form of validity was also deemed 
most appropriate for study given the presence of a 
well-defined content or criterion (i.e., DSM-III-R) for 
classifying individuals.
The PIMRA has been a frequently studied measure. 
However, this was the first study specifically designed to 
test the validity of the schizophrenia subscale. Given the 
urgent need to develop assessment in the dual diagnosis 
field and the fact that, at present, no other scales exist, 
which serve to measure schizophrenia in the mentally 
retarded population, this study may be considered an 
important advance in dual diagnosis research.
The depression subscale of the PIMRA has been 
sufficiently validated. However, given the presence of a 
depression comparison group in the present study, the same
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procedures used to validate the schizophrenia subscale were 
also used in replicating the validation of the depression 
subscale.
The fact that the other PIMRA subscales might provide 
useful information for identifying schizophrenia which is 
not available when considering the schizophrenia subscale 
alone provides the rationale for the third goal of the 
present study. The goal was to determine whether utilizing 
some combination of the PIMRA subscales (rather than 
relying on individual subscales) would enhance the 
diagnostic ability of this measure. That is, would 
consideration of other subscales help discriminate between 
diagnostic groups? Do the subscales provide overlapping 
information? Perhaps differential diagnosis may be 
enhanced by considering the exclusionary and inclusionary 
criteria of the various forms of psychopathology rather 
than limiting the scope to the schizophrenia subscale.
As an added measure of the criterion validity of both 
the schizophrenia and depression subscales, a drug response 
measure was administered. The correlation between the 
response to medication and the type and/or severity of the 
disorder (reflected by PIMRA scores) was evaluated. It was 
hypothesized that the response to medication would decrease 
with the increasing severity of the disorder.
In sum, this study was important for establishing the 
criterion validity of the schizophrenia subscale of the
PIMRA. It was also important for further confirming the 
diagnosis of schizophrenia in mentally retarded persons. 
The primary hypothesis investigated by the study was that 
individuals diagnosed with a dual diagnosis of mental 
retardation and schizophrenia would score higher on the 
schizophrenia subscale of the PIMRA than mentally retarded 
depressed individuals and mentally retarded individuals 
with no form of psychopathology.
Method 
Subjects and Setting 
Sixty-five mildly to moderately mentally retarded 
adults residing in group homes or institutions in Louisiana 
and Texas were recruited. Data collection began after 
appropriate consent was obtained. Subjects' suitability 
for the study was based on chart notes and/or current 
diagnoses.
Level of intellectual functioning was obtained from 
the subjects' medical records. Subjects were matched on 
age and sex between groups. Subject demographics are 
presented in Table 1. It should be noted that subjects in 
each group were not equally represented from institutional 
and community settings, nor were they equally sampled from 
the various facilities utilized in the study.
Mentally Retarded Group (n=22)
These subjects met the American Association on Mental 
Retardation (AAMD) criteria for mental retardation. They 
function within the mild to moderate ranges of mental 
retardation.
Mentally Retarded Schizophrenia Group (n=22)
These subjects met the AAMD criteria for mild or 
moderate mental retardation as described above. In 
addition, they were classified as schizophrenic by a 
trained professional (e.g., psychiatrist, psychologist).
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Mentally Retarded Depression Group (n=21)
These subjects also met the AAMD criteria for mild or
moderate mental retardation. Furthermore, they received a
diagnosis of major depression or dysthymia from a trained





















Information regarding the subjects' basic 
demographics (e.g., age, sex), past and present psychiatric 
symptomatology, and intellectual and adaptive functioning 
was obtained from informants familiar with the subjects by 
raters blind to diagnoses. Informant demographics are 















Checklists for schizophrenia, major depression, and
dysthymia (see Appendix C) were administered concurrently
to two separate informants who knew the subject well (e.g.,
caseworker) by a rater blind to the diagnosis of the
subject. Checklists were derived directly from diagnostic
criteria outlined in the DSM-III-R.
Table 2 
Informant Demographics
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master's or doctoral training
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Each subject given psychopharmacological treatment 
was rated on a scale from one (low drug response) to five 
(high drug response) as to the subject's response to that 
treatment based on information from an informant who knew 
the subject well (see Appendix D ) . The level of drug
response was determined by evaluating considerations such 
as whether the individual had a large number of drug 
changes in the recent past (possibly indicating difficulty 
in identifying an effective drug and/or dose) and whether 
the individual had fewer overt symptoms than in the past 
(possibly indicating drug effectiveness). Of the total 
population, 36 were on medication (21 schizophrenic, 15 
depressed). No individuals in the no psychopathology group 
were on medication. Ratings were completed based on 
information provided by one informant for all subjects on 
medication and based on information provided by two 
separate informants for 42% of these cases.
The Psychopathology Instrument for Mentally Retarded Adults 
(PIMRA)
The rating-by-others form of this measure was 
administered by persons specifically trained to do so. 
Ratings were based on information obtained from individuals 
who knew the subject for at least a one-month period. For 
31% of the cases, the rater (blind to diagnosis) obtained 
information from two informants.
Data Analyses 
The first two goals of the study (i.e., criterion 
validity of the schizophrenia and depression subscales of 
the PIMRA) were addressed in three ways. First, eight 
separate one-way ANOVA's were performed on the eight 
subscales of the PIMRA. The scores from these subscales
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served as the dependent variables to determine whether the 
diagnostic groups differed significantly on each of these 
variables. Most importantly, individuals in the 
schizophrenic group were expected to score higher than the 
other group members on the schizophrenia subscale.
Likewise, members of the depressed group were hypothesized 
to score higher than the other group members on the 
depression subscale.
If the PIMRA is to be considered useful for 
classification purposes, it should be highly correlated 
with another measure standardly used for this purpose. 
Therefore, pearson correlations between PIMRA subscale 
scores and the core criteria of the DSM-III-R checklists 
were completed with the DSM-III-R core criteria serving as 
a further criterion measure of the PIMRA's validity.
Another approach to establishing the criterion 
validity of the schizophrenia (and depression) subscale of 
the PIMRA was to perform a stepwise discriminant function 
analysis (DFA) . In this way, it was established whether 
individuals with higher scores on the schizophrenia 
subscale of the PIMRA tended to be classified as members of 
the schizophrenia group. Similarly, individuals with 
higher scores on the depression subscale were expected to 
be classified as depressed.
Lastly, the drug response measure was included as 
the fourth measure of the criterion validity of these
subscales of the PIMRA. As the drug response rating 
increased, less overt symptoms of psychopathology were 
expected to be evident (i.e., low PIMRA scores). The 
pearson correlation coefficient was calculated for the 
subscales to determine the correlation or relationship 
between the level of drug response and the symptomatic 
nature of the psychopathology. The stepwise DFA was also 
utilized in addressing the third goal of the study to 
provide a test of discriminant validity. Discriminant 
validity relates to the ability of one scale to serve as an 
effective predictor of group membership. For example, the 
schizophrenia subscale may be said to have adequate 
discriminant validity if the score on this scale alone 
(rather than some combination of scale scores) is 
sufficient to predict whether the individuals belong to the 
schizophrenia, depression, or no psychopathology group.
Finally, interrater reliability was conducted on the 
DSM-III-R checklists, drug response ratings, and PIMRA 
responses. This reliability was calculated based on 
ratings derived from two independent informants for 100% of 
the subjects on the DSM-III-R checklists and at least 25% 
of the subjects on the other two measures. Reliability was 
reported using Cohen's Kappa.
Results 
Primary Analyses 
Analysis of Variance (ANOVA)
Eight separate one-way ANOVA's were calculated with 
PIMRA subscale scores serving as the dependent measures and 
group membership serving as the independent variable. 
Analyses were conducted as an initial step in determining 
whether there were significant differences in scale scores 
as a function of group membership. Specifically, it was 
hypothesized that individuals in the schizophrenia group 
would score higher than the other groups on the 
schizophrenia subscale. These analyses, as opposed to a
Table 3 
ANOVA












MANOVA, were conducted in that the primary research 
interest was in group differences on each separate subscale 
score rather than in differences as determined by the 
combination of subscale scores or overall PIMRA score. In
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addition, MANOVA's are generally avoided given the 
increased complexity and ambiguity of results obtained with 
this procedure. As previously mentioned, seven items 
compose each subscale. At least four of the seven items 
must be endorsed to make the diagnosis represented by the 
particular subscale. Symptoms generally ranged from 
paranoia and delusions for the schizophrenic subjects and 
suicidal ideation, flat affect, and increased sleep for the 
depressed subjects.
The results of these analyses are presented in Table 
3. Significant differences in scale scores at the p<.05 
level were found between diagnostic groups -for the 
schizophrenia and affective disorder subscales and the 
total scale only. The affective disorder subscale and the 
total scale scores reflect significant group differences at 
the pc.Ol level of significance. The schizophrenia 
subscale score, however, reflects significant group 
differences at p<.02.
Post-hoc analyses using Tukey's HSD method confirm the 
significance of the scale score differences reported above. 
That is, the mean score differences equalled or exceeded 
the HSD at the p<.05 level of significance. The 
significance of the mean score differences are further 
reflected in the mean scale score comparisons for the 




Subscale and Total Scores
Subscale Schiz Depr No Psych
Schizophrenia (SD=1.47) 2 .10* 1.85 .86*
Affective D/0 (SD=1.76) 1.76* 3.38*, ** 1.23**
Psychosexual D/0 (SD=.72) .41 .29 .23
Adi us tment D/0 (SD=1.80) 2 .24 2 .10 1.50
Anxiety D/0 (SD=1.66) 2.67 2 .43 1.59
Somatoform D/0 (SD=1.61) .91 1.43 . 82
Personality D/0 (SD=1.53) 2 .14 1.86 1.27
Inappropriate Adj (SD=1.66) 2 . 71 2 .29 1. 63
Total (SD=5.75) 16.59 18 . 00* 12.86*
*/** significantly different @ p < .05
presented on this latter table are indications of which
group mean scores were significantly different from each 
other at the p<.05 level. According to these results, both 
the schizophrenia and depression groups scored 
significantly higher (on average) than the no 
psychopathology group on the schizophrenia subscale. 
However, significant group differences were not found 
between the schizophrenia group and depression group. 
Therefore, the results of these analyses reflect some 
validity for the schizophrenia subscale. However, the 
results lend greater support for the validity of the 
affective disorder subscale in that significant differences 
in group means were found between the depressed group and 
both the schizophrenia and no psychopathology groups.
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Discriminant Function Analyses (DFA)
A stepwise DFA was conducted with subscale scores and 
group membership functioning as the independent and 
dependent variables, respectively. The goal of these 
analyses was to determine which subscales were most 
predictive of group membership. Specifically, it was 
hypothesized that individuals with higher scores on the 
schizophrenia subscale of the PIMRA would be classified as 
members of the schizophrenia group. This analysis was also 
utilized to determine whether the schizophrenia subscale 
had adequate discriminant validity (i.e., whether the score 
on the schizophrenia subscale alone was sufficient to 
predict membership of schizophrenic and non-schizophrenic 
subjects). Discriminant function analysis was considered 
to be an appropriate analysis for this study in that the 
ability of different combinations of scores to predict 
group membership was of interest. On the other hand, how 
groups differed in scores derived from a combination of 
scales per se was not of particular interest. Further, 
since MANOVA's and DFA's are mathematically identical, it 
was determined that to carry out a MANOVA would be 
redundant and unnecessary.
From Table 5, it is evident that the affective 
disorder subscale overall was most predictive of group 
membership. The affective disorder subscale served as a 
predictor of membership in all three diagnostic groups even
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Table 5
Discriminant Function Analysis 
PIMRA Subscales
Variable # Variables Wilks'
Step Entered In Lambda
1 Affective D/0 1 .68
2 Inappropriate Adj 2 .54
3 Schizophrenia 3 .49
4 Anxiety D/O 4 .45
5 Somatic D/O 5 .41
6 Psychosexual D/O 6 .39
p < .0001
standing alone. In contrast, it does not appear from these 
analyses that the schizophrenia subscale could stand alone 
in predicting these same classifications. However, the 
fact that this subscale was entered at a significant level 
into the analyses indicates that the score from this 




Actual Group Schizophrenia Depression No Psychopath
Schizophrenia 78.90% 5.30% 15.80%
Depression 10.00% 70.00% 20.00%
No Psychopath 22.70% 18.20% 59.10%
discriminating between the three diagnostic groups. Table 
6 reflects the percentage of individuals from each 
diagnostic group who were correctly classified using the 
combination of scales presented in Table 5. Overall, 
68.85% of the cases were correctly classified.
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Table 7
Discriminant Function Analysis 
PIMRA Subscales 
Schizophrenic vs Non-Schizophrenic
Variable # Variables Wilks'
Steo Entered In Lambda
1 Schizophrenia 1 .92
2 Affective D/O 2 .82
3 Inappropriate Adj 3 .73
4 Anxiety D/O 4 . 67
5 Somatic D/O 5 . 61
6 Psychosexual D/O 6 .59
p < . 05
Also investigated was whether the schizophrenia
subscale is adequate in correctly classifying two groups 
(i.e., schizophrenic and non-schizophrenic individuals) 
from one another. The results presented in Table 7 
indicate that the schizophrenia scale was most useful in 
making this discrimination. However, it also appears that 
utilizing a combination of several other scales is best in 
this pursuit. Specifically, Table 8 reflects the 
percentage of individuals from the schizophrenic and 
non-schizophrenic groups (i.e., depressed and no 
psychopathology) who were correctly classified using the 
combination of scales presented in Table 7. Overall, 
80.33% of these individuals were classified correctly.
Alternatively, when the discrimination between 
depressed and nondepressed individuals is desired, the 






Actual Group Schizophrenia No Schizophrenia
Schizophrenia 84.20% 15.80%
No Schizophrenia 21.40% 78.60%
this discrimination (see Table 9). Again, however, the 
best prediction may be achieved by using a combination of
Table 9
Discriminant Function Analysis 
PIMRA Subscales 
Depressed vs Non-depressed
Variable # Variables Wilks'
Step Entered In Lambda
1 Affective D/O 1 . 69
2 Inappropriate Adj 2 . 61
3 Somatic D/O 3 .59
4 Personality D/O 4 .58
p < .0001
scales (i.e., affective disorder, inappropriate adjustment,
somatic disorder and personality disorder subscales). When













as presented in Table 10 with 79.37% of the cases 
classified correctly overall.
Interrater Reliability
For the purpose of calculating interrater reliability, 
raters completed a second set of DSM-III-R checklists, 
PIMRA, and drug response measures. This second set of 
information was based on responses from a second and 
independent informant for all subjects (100%) for the 
DSM-III-R checklists, 20 subjects (31%) for the PIMRA, and 
15 subjects (23.0% of all subjects and 41.7% of those on 
medication) for the drug response ratings. The 
investigator of this project randomly determined the 
subjects used in the calculation of interrater reliability.
Cohen's Kappa. Reliability information for the 
DSM-III-R checklist items are grouped according to 
checklist and are presented in Appendix E. Interrater 
reliability for these items was calculated in terms of 
percent agreement ([[agreements]/ [agreements + 
disagreements]] * 100). Interrater reliability was also 
calculated in terms of Cohen's Kappa. Kappa coefficients 
are more conservative measures of reliability in that they 
reflect values after controlling for chance agreement. It 
should be noted at the outset that most studies do not 
report kappa values. Rather, percent agreement (a less 
conservative measure of reliability) is reported.
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Therefore, these values should be considered when comparing 
the results of the present study with other studies.
Mean percentage agreement across these items were 
78.16% for the schizophrenia checklist, '77.57% for the 
dysthymia checklist, and 80.65% for the major depression 
checklist. Kappa values for most items on the 
schizophrenia checklist ranged from .03 to .59. These 
values reflect poor to moderate agreement (Wilkinson,
199 0). For the dysthymia checklist, most items had kappa 
values that ranged from .17 to .69, indicating poor to good 
agreement. For the major depression checklist, kappa 
values ranged from .23 to .65, indicating poor to moderate 
agreement.
Interrater reliability and kappa coefficient 
information for the PIMRA items (grouped according to 
subscale) are detailed in Appendix F. Mean percentage 
agreement across these subscale items is 80.06%. Most 
kappa values for the subscales ranged from .06 to 1.00, 
reflecting poor to perfect agreement. Kappa values could 
not be calculated for several items in that they were 
scored 0 by all or most raters. The mean percent agreement 
for the subscale of interest (i.e., the schizophrenia 
subscale) was 85.60%. The kappas for the Items on this 
scale ranged from .47 to .86, indicating moderate to good 
agreement.
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Lastly, the percentage agreement for the ratings on 
the drug response measure is 66.70%. The kappa value for 
this rating is .52, reflecting moderate agreement.
Pearson correlations. Pearson correlations were 
conducted for the purpose of calculating interrater 
reliability of composite scores such as the core criteria 
on the DSM-III-R checklists. Core criteria refers to 
criteria referring to specific symptomatology (e.g., 
delusions, insomnia, decreased energy) rather than to 
criteria used as exclusion criteria (e.g., no history of 
autism, not maintained or initiated by an organic factor).
The decision to utilize these criteria in the analyses 
rather than the total number of endorsed criteria or the 
specification of meet versus don't meet the criteria was 
based largely on anecdotal information. Informants 
appeared to have difficulty in understanding the exclusion 
criteria portions of the checklists and would answer 
inconsistently between and within checklists.
Additionally, they made comments inconsistent with their 
endorsements (e.g., endorsed no history of manic or 
hypomanic episodes but elsewhere indicated that manic 
episodes were a problem in the past, endorsed that the 
symptoms were not normal reactions to death of a loved one 
yet noted elsewhere the recent death of a family member. 
Therefore, this effected both the total number of criteria 
endorsed on the checklists and, subsequently, whether the
subjects met the diagnoses. The more readily 
comprehensible core criteria, therefore, served as the 
bases for these and other correlations. However, given the 
difficulties on the items excluded from the analyses, some 
caution regarding the results obtained with the core
Table 11
Interrater Reliability/DSM-III-R
DSM-III-R Checklist Pearson Correlation
Schizophrenia .55**
Dysthymia .38**
Major Depression . 61**
**p<.01
criteria which were included is warranted.
According to the information presented in Table 11, 
correlations between informant ratings of the number of 
main criteria endorsed on the DSM-III-R checklists are 
significant at the pc.Ol level. These results reflect good 
interrater reliability for the subset of core criteria 
selected for inclusion in these analyses.
Pearson correlations were also calculated for subscale 
and total scores on the PIMRA. A high correlation between 
scores on most scales derived from information obtained 
from two independent informants reflects adequate 
reliability (see Table 12).
Other Analyses 
Pearson correlations were obtained between the PIMRA 
schizophrenia and affective disorder subscale scores and 
the drug response ratings for the schizophrenia and 
depression groups, respectively, to investigate the 





Affective D/O . 73**





Inappropriate Adj . 71**
Total . 74**
*p<.05 **p<.01
psychopathology and the response to medication (i.e., drug 
response rating). It was hypothesized that those with 
higher subscale scores should have lower ratings on the 
drug response measure, reflecting more overt symptomatology 
secondary to a poorer response to medication. Although the 
trends of resulting correlations were in the expected 
direction, they cannot be interpreted given the 
non-significance of these correlations. The small n in 
this study may explain the null outcomes with respect to 
these correlations.
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Pearson correlations were also computed between PIMRA 
subscale scores and the core criteria endorsed on the 
DSM-III-R checklists. This comparison was investigated 
using the DSM-III-R items as a further criterion measure 
and as a means of determining how well correlated the PIMRA 
is to items standardly used for diagnostic classification 
in clinical practice. As previously mentioned, if the 
PIMRA is to be considered useful for classification 
purposes, it should be highly correlated with another 
measure specifically designed for this purpose. The 
correlation between the DSM-III-R schizophrenia checklist 
and the PIMRA schizophrenia subscale was .43, reflecting a 
significant correlation at the p<.05 level. The 
correlations between the PIMRA affective disorder subscale 
and the DSM-III-R dysthymia and major depression checklists 
were .58 and .16, respectively. Only the former 
correlation (i.e., .58) was significant at -the pc.Ol level
of significance and reflected a fair to moderate level of 
correlation. A significant correlation was not found in 
the latter case.
Discussion
As previously mentioned, some validation research with 
the PIMRA has been reported. Preliminary investigations of 
this measure have indicated initial support for the 
validity of the affective disorder subscale (e.g., Kazdin 
et al., 1983; Sturmey & Ley, 1990). In addition, 
researchers have suggested the use of the PIMRA as a 
general inventory of psychopathological symptoms (Senatore 
et al., 1985). However, validity of other subscales must 
be addressed to further delineate the utility of the PIMRA 
in diagnosing psychopathology in the mentally retarded 
population. Given the need for standardized measures of 
schizophrenia in the mentally retarded population, 
validation of the schizophrenia subscale of the PIMRA was 
pursued.
The present study was conducted with the primary goal 
of establishing the criterion-related validity of the 
schizophrenia subscale of the PIMRA. Given the fact that 
the items of the PIMRA are based on a well ‘established 
standard for classification (e.g., DSM-III criteria), it 
would appear that the PIMRA is a good candidate for 
predicting group membership. The second goal was to 
utilize the same procedures for validating the 
schizophrenia subscale to replicate the validation of the 
depression subscale of the PIMRA. The third goal was to 
determine whether utilization of some combination of PIMRA
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subscales would help discriminate between diagnostic 
groups. The findings as related to these goals will be 
discussed next.
Significant differences were found between the 
schizophrenia and no psychopathology groups on the 
schizophrenia subscale scores. In addition, significant 
group differences were found between the depression and the 
no psychopathology groups on total scores of the PIMRA. 
Although significant differences were not obtained between 
the schizophrenia and depression groups, trends are in the 
hypothesized direction. However, the group differences on 
the affective disorder subscale were significant and 
demonstrated that, unlike the schizophrenia scale, group 
differences occurred not only between the depression and no 
psychopathology group, but also between the depression and 
schizophrenia group.
In carrying the analyses further to afford better 
interpretation, discriminant function analyses were 
conducted for PIMRA subscales. From these analyses, it was 
determined that the schizophrenia subscale was a 
significant predictor of group membership for the three 
groups of subjects. However, this scale could not stand 
alone in making this prediction.
Although the ability of the schizophrenia scale to 
appropriately classify schizophrenic subjects as well as 
depressed and no psychopathology subjects into their
respective groups is important, the question of primary 
consideration in the present investigation is whether the 
schizophrenia scale is adequate in correctly classifying 
two groups (i.e., schizophrenic and non-schizophrenic 
individuals) from one another. With regards to this 
question, the schizophrenia scale was again an important 
predictor for discriminating between schizophrenic and 
non-schizophrenic individuals but its prediction was 
enhanced when it did not stand alone in this endeavor. It 
was also determined that the affective disorder scale was 
useful in discriminating between all three diagnostic 
groups included in the analyses and an even better 
predictor for discriminating depressed from nondepressed 
subj ects.
These analyses lend initial support for the validity 
of the schizophrenia subscale for classifying schizophrenic 
and non-schizophrenic individuals. The results may also be 
considered a further indication of the validity of the 
affective disorder subscale as reported by .other authors 
(e.g., Kazdin et a l ., 1983; Sturmey & Ley, 1990).
Substantiation of the criterion-related validity of 
both the schizophrenia and affective disorder subscales of 
the PIMRA was not achieved with the correlations found 
between the scores on these subscales and the drug response 
measure. Although the relationships were nonsignificant, 
the trends of these correlations did potentially indicate
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that the worse the response to medication, the more 
symptomatic the individual with respect to psychopathology. 
Overall, these results must be tempered with some 
statistical and other issues. For instance, the sample 
size with regards to those on medication is very small. 
Therefore, the fact of a non-significant correlation could 
be attributed to factors other than an insignificant 
correlation. That is, a couple of outliers or low variance 
could make a large impact on a small sample and result in 
an insignificant correlation. In addition, another 
potential confounding factor is whether the subjects are 
receiving medication efficacious to their particular 
symptomatology and/or whether they are being sufficiently 
monitored on their medication. It is possible that one may 
not be able to assume the positive and that the results and 
interpretations might differ if these assumptions could be 
made.
Moreover, the DSM-III-R checklists served as further 
criteria for determination of the criterion-related 
validity of the PIMRA subscales. These checklists were 
considered important criteria for comparison since they 
currently serve as the standard for diagnosis in psychology 
and psychiatry. The high correlation of the schizophrenia 
and affective disorder scales of the PIMRA with their 
respective DSM-III-R checklists indicates that these PIMRA 
scales are reasonable and valid criteria for classification
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purposes in that they reflect similar trends as the 
commonly used DSM-III-R criteria.
Finally, it is necessary to address the issue of 
reliability when addressing validity. A conclusion 
regarding validity cannot be made without considering 
reliability. That is, a scale may measure what it purports 
to measure, but if the results cannot be replicated, they 
are of little utility. Regarding this issue, interrater 
reliability ranged from poor to excellent for the PIMRA 
items, a finding similar to that of other investigations 
(e.g., Iverson & Fox, 1989) and poor to good for the 
DSM-III-R checklist items. The often low kappa values may 
be more of an artifact of the sample size than of the 
actual reliability of the PIMRA items. That is, the 
smaller the sample size, the more the possibility that 
cells with small n exist and that effects of outliers will 
be exaggerated. Nonetheless, agreement on the 
schizophrenia items of the PIMRA in particular was moderate 
to good. In addition, the subscale scores of the PIMRA and 
the DSM-III-R checklists indicate good interrater 
reliability. Further, the drug response ratings showed 
moderate agreement. It is important to bear these results 
in mind when making conclusions regarding the primary 
analyses.
The present study made several advances on research in 
the area of dual diagnosis and, more specifically, on the
Meadows et al. (1991) study previously mentioned. Meadows
et al. (1991) also pursued a validation of a particular
measure (SADS-L) for assessing schizophrenia in mentally 
retarded persons. The authors were concerned with a 
comparison of two schizophrenic groups (one with normal 
intelligence and one with mental retardation) and utilized 
the same measure to identify schizophrenia in both 
populations. The measure was neither designed to measure 
schizophrenia in mentally retarded individuals nor has it 
been standardized or validated for use with this 
population. It also involves a quite laborsome interview 
format. In addition, the authors did not provide a 
rationale for using the same measure for both normal 
intelligence and mentally retarded populations given the 
relative deficits of the latter population in expressive, 
functional, and other developmental abilities. Finally, 
the mentally retarded group utilized in the Meadows et al. 
(1991) study was limited to individuals with mild mental 
retardation. Perhaps the conclusions (i.e., that the 
SADS-L was valid for use in identifying schizophrenia in 
both individuals with and without mental retardation) would 
have been different had the authors used a more severely 
mentally retarded population.
In the present research, however, a measure 
specifically designed for assessing mental illness in 
mentally retarded individuals (i.e., PIMRA)- was utilized
with a mild/moderate group of mentally retarded 
individuals. The ability of specific subscales of the 
measure to identify specific psychopathology in the 
mentally retarded individuals participating in the study 
was addressed. The advantage of this measure is that it is 
specifically designed for use with mentally retarded 
persons and can be used to identify several specific types 
of psychopathology rather than solely schizophrenia in this 
population. The present study is one step .in the direction 
of validating the measure for this purpose.
Despite the advances made by this project toward the 
validation of a much needed assessment measure for the 
assessment of mental illness in mentally retarded persons, 
the results of the research have several limitations.
First, subjects in the present study resided in Louisiana 
and Texas, providing only a limited sampling. In addition, 
the subjects were not equally represented in each facility 
utilized in the study. Policies regarding 'the residential 
placement of mentally retarded persons varies in different 
locations. Therefore, it is possible that subjects 
recruited from different geographic areas (or different 
mental retardation facilities within a geographic area) are 
classified and/or present differently and the 
representativeness of the sample must be questioned.
Future research should replicate the present study 
utilizing subjects from other and more varied geographic
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regions as well as more equally sample the facilities 
within the geographic areas chosen.
Second, although subjects in the present study resided 
in both institutional and community settings, most of these 
individuals resided in inpatient facilities. Individuals 
who are institutionalized are more likely to have more 
severe behavior problems. In addition,
institutionalization may serve to promote and/or maintain 
the behavioral and/or psychiatric problems. Therefore, the 
data presented here may not be representative of adults 
residing in community placements. This should be further 
addressed in future research.
Also, third party informants were used exclusively in 
this research rather than relying on the more direct 
account collected through self-report or interview data. 
Reports from caregivers may lead to misdiagnosis when the 
caregiver has particular sensitivity to certain behaviors 
or tolerance and habituation to other behaviors (Costello, 
1982; Lewis & MacLean, 19 82). However, given the 
limitations in the verbal capacity of mentally retarded 
individuals, self-report and interview data would be 
difficult to collect and interpret. In fact, informant 
data might just be the most viable means for studying these 
individuals (Aman, 1991). In addition, different widely 
used scales (e.g., Vineland ABS, Childhood Autism Rating 
Scale) in the field of mental retardation and developmental
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disabilities rely on third-party data and have had their 
psychometric properties adequately substantiated through 
empirical research (Sparrow, Balia, & Cicchetti, 1984; 
Schopler, Reichler, & Renner, 1988).
A further issue relates to the difficulties in 
diagnosing and assessing schizophrenia in mentally retarded 
individuals. These difficulties arise due to overlapping 
symptomatology between schizophrenia and mental 
retardation. In addition, in that many mentally retarded 
individuals are not verbally expressive, it is often 
difficult to detect the presence of many of the 
schizophrenic symptoms. Finally, disagreement persists in 
the literature regarding which criteria are necessary and 
sufficient for the diagnosis of schizophrenia, mental 
retardation, and more specifically for schizophrenia in 
mentally retarded individuals. Given these difficulties, 
it would be reasonable to question the extent to which the 
sample in this study truly represents the population of 
interest. Perhaps utilization of another measure of 
schizophrenia using a standardized instrument would have 
helped to ensure a correct classification of schizophrenia 
(to the extent to which this is possible). Nonetheless, 
some support for the representativeness of our sample may 
be obtained from the results presented from this research. 
Referring to the mean scores in Table 4, it is apparent 
that although the differences in scores are not
significantly different between all three groups, the 
scores do fall in the expected direction with the 
schizophrenia group scoring highest on the schizophrenia 
scale. In addition, the classification results presented 
in Table 6 indicate that a large percentage of those 
diagnosed with schizophrenia were also scored as such on 
the schizophrenia subscale and at a much higher rate than 
the other groups. Therefore, it is believed that the 
subjects classified as schizophrenic in this study are 
truly representative of the schizophrenic population.
Finally, the results of the discriminant function 
analyses should be interpreted with some degree of caution. 
These analyses have typically presented some controversy. 
This controversy has centered around both theoretical 
(e.g., causality, generalizability) and practical (unequal 
sample sizes, missing data, outliers, linearity) 
limitations of this statistical technique. The 
controversial aspects of this technique are even more 
prevalent with the stepwise version of this technique. For 
example, the order in which variables are entered into the 
discriminant function may be determined by .insignificant 
sample differences between variables that are not 
representative of population differences (Tabachnik & 
Fidell, 1983) . Though consideration of these limitations 
are important, this does not preclude the ability to derive 
some preliminary but important information from the
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analyses conducted in this research. In fact, despite the 
limitations of this statistical technique, it was 
considered most useful in the context of this research in 
that it gives great attention to the numerous variables on 
which group membership differs. Furthermore, through this 
methodology it is possible to learn more about the source 
of group differences by determining the specific 
contribution of each proposed predictor in attempts to 
determine which predictors are most critical in correctly 
classifying individuals (Tabachnik & Fidell, 1983).
Future studies of the PIMRA should continue to pursue 
the validity of the measure in the diagnosis and assessment 
of the various forms of psychopathology for which the 
measure was designed. Researchers may also wish to 
determine the role of medication in results from the PIMRA. 
That is, how do the results of the analyses in this study 
change when one compares individuals on medication and 
those who are not? Alternatively, how do these same 
results change when considering not just those who are on 
medication but also those who are controlled on medication 
and those who are not?
In conclusion, although a dearth of assessment 
measures specifically devised for the assessment of 
mentally retarded individuals exists, it is not wise from 
the standpoint of good clinical practice to utilize 
measures neither standardized nor validated for use with
this population. The PIMRA may prove to fill one void in 
the area of dual diagnosis by serving as an assessment 
measure to identify various forms of psychopathology in 
dually diagnosed persons. However, various issues 
regarding assessment (e.g., validity, reliability, 
standardization) as well as other issues pertaining to dual 
diagnosis research remain to be investigated and documented 
through controlled and otherwise methodologically sound 
research.
References
Aman, M. G. (1991). Assessing psychopathology and behavior 
problems in persons with mental retardation: A review 
of available instruments. Rockville, MD: U.S. Dept, of 
Health and Human Services.
Aman, M. G., Watson, J. E., Singh, N. N., Turbott, S.H., & 
Wilsher, C.P. (19 86). Psychometric and demographic 
characteristics of the Psychopathology Instrument for 
Mentally Retarded Adults. Psychopharmacology Bulletin. 
22, 1072-1076.
American Psychiatric Association (1980) . Diagnostic and 
statistical manual of mental disorders (3rd 
ed., DSM-III). Washington, D. C.: American 
Psychiatric Association.
American Psychiatric Association (1987). Diagnostic and 
statistical manual of mental disorders (3rd ed., 
revised, DSM-III-R). Washington, D. C.: American 
Psychiatric Association.
Anthony, E. J. (1978). Concluding comments on treatment 
implications. In L. C. Wynne, R. L. Cromwell, & S. 
Matthysse (Eds.), The nature of schizophrenia: New
approaches to research and treatment. New York: Wiley 
Medical.
Ballinger, B. R., Armstrong, J., Presly, A. S., & Reid, A.
H. (1975) . Use of a standardized psychiatric interview 
in mentally handicapped patients. British Journal of 
Psychiatry. 127. 540-544.
Ballinger, B. R., Ballinger, C. B., Reid, A. H., &
McQueen, E. (1991). The psychiatric symptoms, 
diagnoses and care needs of 100 mentally handicapped 
patients. British Journal of Psychiatry. 158. 251-254.
Barchas, J. D., Elliott, G. R., & Berger, P. A. (1978).
Biogenic amine hypotheses of schizophrenia. In L. C. 
Wynne, R. L. Cromwell, & S. Matthysse (Eds.), The 
nature of schizophrenia: New approaches to research 
and treatment. New York: Wiley Medical.
Bartak, L., & Rutter, M. (1976). Difference between
mentally retarded and normally intelligent autistic 
children. Journal of Autism and Childhood 
Schizophrenia. 6., 109-120.
Bleuler, E. (1950). Dementia praecox or the group of
schizophrenias. New York: International Universities 
Press. (Originally published, 1911.)
77
78
Braginsky, B. M . , Braginsky, D. D., & Ring, K. (1969).
Methods of madness: The mental hospital was a last
resort. New York: Holt Rinehart & Winston.
Carlsson, A. (1970). Amphetamine and brain catecholamines. 
In E. Costa & S. Garantine (Eds.), Amphetamines and 
related compounds. New York: Raven Press.
Carpenter, W. T., & Strauss, J. S. (1979). Diagnostic
issues in schizophrenia. In L. Beliak (Ed.), Disorders 
of the schizophrenic syndrome. New York: Basic Books.
Carpenter, W. T., Strauss, J. S., & Bartko, J. J. (1973). A 
flexible system for the identification of 
schizophrenia. Science. 182. 1275-1278.
Carpenter, W. T., Strauss, J. S., & Muleh, .S. (1973) . Are
there pathogomonic symptoms in schizophrenia? An 
empiric investigation of Kurt Schneider's first rank 
symptoms. Archives of General Psychiatry. 2 8 , 847-852.
Carson, R. C. (1984). The schizophrenias. In H. E. Adams & 
P. B. Sutker (Eds.), Comprehensive handbook of 
psychopathology (pp.411-438). New York: Plenum Press.
Costello, A. (1982) . Assessment and diagnosis of
psychopathology. In J. L. Matson & R. P. Barrett 
(Eds.), Psychopathology in the mentally retarded. New 
York: Grune & Stratton, Inc.
Davis, J. M. (1978) . Dopamine theory of schizophrenia: A 
two-factor theory. In L. C. Wynne, R. L. Cromwell, &
S. Matthysse (Eds.), The nature of schizophrenia: New
approaches to research and treatment. New York: Wiley 
Medical.
Dohrenwend, B. P., & Egri, G. (1981). Stressful life events 
and episodes of schizophrenia. Schizophrenia Bulletin. 
7, 12-23.
Drake, R. E., & Wallach, M. A. (1979). Will mental patients 
stay in the community? A social psychological 
perspective. Journal of Consulting and Clinical 
Psychology. 47. 285-294.
Eaton, L., & Menolascino, F. (1982). Psychiatric disorders 
in the mentally retarded: Types, problems and 
challenges. American Journal of Psychiatry. 139. 
1297-1303.
Edgerton, R.B. (1985). The cloak of competence. Berkeley: 
University of California Press.
79
Endicott, J., & Spitzer, R. L. (1978). A diagnostic
interview: The schedule for affective -disorders and 
schizophrenia. Archives of General Psychiatry. 35. 
837-844.
Eyman, R. K., & Call, T. (1977). Maladaptive behavior and 
community placement of mentally retarded persons. 
American Journal of Mental Deficiency. 82. 137-144.
Feighner, J., Robins, E., Guze, S., Woodruff, R., &
Munoz, R. (1972). Diagnostic criteria for use in 
psychiatric research. Archives of General Psychiatry. 
26, 57-63.
Fischer, J. (1969). Negroes and whites and rates of mental 
illness: Reconsideration of a myth. Psychiatry. 32. 
428-446.
Fraser, W. I., Leudar, I., Gray, J., & Campbell, I. (1986). 
Psychiatric and behaviour disturbance in mental 
handicap. Journal of Mental Deficiency Research. 30. 
49-57.
Goldberg, D. P., Cooper, B., Eastwood, M. R., Kedward, H.
B., Sc Shepherd, M. (1970). A standardised psychiatric 
interview for use in community surveys. British 
Journal of Preventative Social Medicine. 24, 18-23.
Golden, C. J., Maclnnes, W. D., Ariel, R. N., Ruedrich, S. 
L., Cung-Chou, C., Coffman, J. A., Graber, B., &
Bloch, S. (1982). Cross validation of the Luria 
Nebraska Neuropsychological Battery to differentiate 
chronic schizophrenics with and without ventricular 
enlargement. Journal of Consulting and Clinical 
Psychology. 50. 87-95.
Gostason, R. (1985). Psychiatric illness among the mentally 
retarded: A Swedish population study. Acta 
Psychiatrica. Scandinavica. 71 (Supplement 318).
Gottesman, I. I. (1978). Schizophrenia and genetics: Where 
are we? Are you sure? In L. C. Wynne, R. L. Cromwell,
& S. Matthysse (Eds.), The nature of schizophrenia:
New approaches to research and treatment. New York: 
Wiley Medical.
Gottesman, I. I., & Shields, J. (1972). Schizophrenia and 
genetics: A twin study vantage point. New York: 
Academic Press.
80
Grossman, H. J. (19 83) . Manual of terminology and
classification on mental retardation. Washington,
D.C.: American Association on Mental Deficiency.
Hollingshead, A. B., & Redlich, F. C. (1958). Social class 
and mental illness. New York: Wiley.
Hucker, S. J., Day, K. E., George, S. & Roth, M. (1979).
Psychosis in mentally handicapped adults. In P. Snaith 
& F. E. James (Eds.), Psychiatric illness and mental 
handicap. Ashford: Headley Brothers.
Itard, J. (1932). The wild boy of Aveyron. New York:
Century. Janowsky, D. S., El-Yousef, M. K., Davis, J. 
M., & Sekerke, H. J. (1973). Provocation of 
schizophrenic symptoms by intravenous administration 
of methylphenidate. Archives of General Psychiatry.
28, 185-191.
Kallman, F. J. (1946). The genetic theory of schizophrenia. 
American Journal of Psychiatry. 103. 309-322.
Kanner, L. (1943). Autistic disturbances of affective 
contact. Nervous Child. 2, 217-250.
Kazdin, A. E., Matson, J. L., & Senatore, V. (1983).
Assessment of depression in mentally retarded adults. 
American Journal of Psychiatry. 140. 1040-1043.
Kety, S. S., Rosenthal, D., Wender, P. H., .Schulsinger, F., 
& Jacobsen, B. (1978). The biologic and adoptive 
families of adopted individuals who become 
schizophrenic: Prevalence of mental illness and other 
characteristics. In L. C. Wynne, R. L. Cromwell, & S. 
Matthysse (Eds.), The nature of schizophrenia: New 
approaches to research and treatment. New York: Wiley 
Medical.
Kohn, M. L. (1973). Social class and schizophrenia: A 
critical review and reformulation. Schizophrenia 
Bulletin. 7, 60-79.
Kraeplin, E. (1896). Psychiatre. Leipzig: J. A. Barth.
(Translated by A. R. Diefendorf (1902) as Clinical 
Psychiatry. New York: MacMillan.)
Kramer, M . , Rosen, B. M . , & Willis, E. M. (1973).
Definition and distribution of mental -disorders in a 
racist society. In C. V. Willie, B. M. Kramer, & B. S. 
Brown (Eds.), Racism and mental health. Pittsburgh: 
University of Pittsburgh Press.
81
Leudar, I., Fraser, W. I., & Jeeves, M. A. (1984).
Behavioural disturbance in mental handicap; typology 
and longitudinal trends. Psychological Medicine. 14. 
923-935.
Levy, S. M. (1976). Schizophrenic symptomatology: Reaction 
or strategy. Journal of Abnormal Psychology. 85. 
435-445.
Lewis, M. H., & MacLean, W. E., Jr. (1982). Issues in
treating emotional disorders. In J. L. Matson & R. P. 
Barrett (Eds.), Psychopathology in the mentally 
retarded. New York: Grune & Stratton, Inc.
Linaker, 0. (1991). DSM-II diagnoses compared with factor
structure of the psychopathology instrument for 
mentally retarded adults (PIMRA), in an 
institutionalized, mostly severely retarded 
population. Research in Developmental Disabilities.
12, 143-153.
Lund, J. (19 85). The prevalence of psychiatric morbidity in 
mentally retarded adults. Acta Psychiatrica 
Scandinavica. 72. 563-570.
Matson, J. L. (1988) . The Psychopathology Instrument for 
Mentally Retarded Adults (PIMRA). International 
Diagnostic Systems, Inc.
Matson, J. L., & Frame, C. L. (1985). Psychopathology in 
mentally retarded children and adolescents. Beverly 
Hills: Sage Publications.
Matson, J. L., Kazdin, A. E., & Senatore, V. (1984). 
Psychometric properties of the psychopathology 
instrument for mentally retarded adults. Applied 
Research in Mental Retardation. 5, 81-89.
McCabe, M. S., & Stomgren, E. (1975). Reactive psychoses: A 
family study. Archives of General Psychiatry. 32. 
447-454.
McNeil, T. F., & Kaij, L. (1978). Obstetric factors in the 
development of schizophrenia: Complications in the 
births of preschizophrenics and in reproduction by 
schizophrenic parents. In L. C. Wynne, R. L. Cromwell, 
& S. Matthysse (Eds.), The nature of schizophrenia:
New approaches to research and treatment. New York: 
Wiley Medical.
82
Meadows, G.; Turner, T., Campbell, L., Lewis, S. W. ,
Reveley, M. A . , & Murray, R. M. (1991) . Assessing 
schizophrenia in adults with mental retardation: A 
comparative study. British Journal of Psychiatry. 158. 
103-105.
Mednick, S. A., Schulsinger, H., & Schulsinger, F. (1975).
Schizophrenia in children of schizophrenic mothers. In
A. Davids (Ed.), Child personality and 
psychopathology: Current topics (Vol. 2). New York: 
Wiley.
Mednick, S. A., Schulsinger, F., Teasdale, T. W . ,
Schulsinger, H., Venables, P., & Rock, D. (1978). 
Schizophrenia in high-risk children: Sex differences 
in predisposing factors. In G. Serban , (Ed.), Cognitive 
deficits in the development of mental illness. New 
York: Brunner/Mazel.
Meltzer, H. Y. (1979). Biochemical studies in
schizophrenia. In L. Beliak (Ed.), Disorders of the 
schizophrenic syndrome. New York: Basic Books.
Menolascino, F. J. (Ed.). (1970). Psychiatric approaches to
mental retardation. New York: Basic Books.
Menolascino, F. J. (1983). Overview: Bridging the gap
between mental retardation and mental illness. In F.
J. Menolascino & B. M. McCann (Eds.), Mental health 
and mental retardation: Bridging the gap. Baltimore: 
University Park Press.
Menolascino, F. J. (19 89). Overview: Promising practices in 
caring for the mentally retarded-mentally ill. In R.
J. Fletcher & F. J. Menolascino (Eds.), Mental 
retardation and mental illness: Assessment, treatment 
and service for the dually diagnosed. Lexington, 
Massachusetts: Lexington Books.
Murphy, D. L. (1973). Mental effects of L-dopa. Annual 
Review of Medicine. 24. 209-216.
Murphy, D. L., & Wyatt, R. J. (1972). Reduced monoamine
oxidase activity in blood platelets from schizophrenic 
patients. Nature, 238, 225-226.
Newmark, C. S., Falk, R., Johns, N., Boren, R., & Forehand, 
R. (1976). Comparing traditional clinical procedures 
with four systems to diagnose schizophrenia. Journal 
of Abnormal Psychology. 85, 66-72.
83
Pollitt, J. (1978). The depressed patient. •Practitioner. 
220. 205-212.
Pond, D. A. (1961). Psychiatric aspects of epileptic and 
brain-damaged children. British. Medical Journal. 2 , 
1377-1382, 1454-1459.
Reid, A. H. (1972). Psychoses in Adult Mental Defectives: 
II. Schizophrenic and paranoid psychoses. British 
Journal of Psychiatry. 220. 213-218.
Reid, A. H. (1989). Schizophrenia in mental retardation: 
Clinical features. Research in Developmental 
Disabilities. 10. 241-249.
Rieder, R. 0. (1979). Children at risk. In L. Beliak (Ed.),
Disorders of the schizophrenic syndrome. New York: 
Basic Books.
Rieder, R. 0., Rosenthal, D., Wender, P., & Blumenthal, H. 
(1975). The offspring of schizophrenics. Archives of 
General Psychiatry. 32. 200-211.
Romanczyk, R. G., & Kistner, J. A. (1982). Psychosis and 
mental retardation: Issues of coexistence. In J. L. 
Matson & R. P. Barrett (Eds.), Psychopathology in the 
mentally retarded. New York: Grune & Stratton.
Rosenthal, D. (Ed.) (1963). The Genain quadruplets. New
York: Basic Books.
Russell, J. F. O. (1988). Psychiatric disorders in adults 
with mental handicap. Current Opinion in Psychiatry.
1, 572-577.
Rutter, M. (1971). Psychiatry. In Wortis (Ed.), Mental 
retardation: An annual review (Vol. 3). New York:
Grune & Stratton.
Rutter, M. (1977). Brain damage syndromes in childhood:
Concepts and findings. Journal of Child Psychology and 
Psychiatry. 18., 1-21.
Rutter, M., & Lockyer, L. (1967). A five to fifteen year
follow-up study of infantile psychosiS-1. Description 
of sample. British Journal of Psychiatry. 113. 
1169-1182.
Rutter, M. , Tizard, J., Yule, W., Graham, P., & Whitmore,
K. (1976). Research report: Isle of Wight studies, 
1964-1974. Psychological Medicine. 6, 313-332.
84
Saenger, G. (1960). Factors influencing the
institutionalization of mentally retarded individuals 
in New York City. Albany: Interdpartmental Health 
Resources Board.
Sanua, V. D. (1970). Immigration, migration, and mental 
illness. In E. B. Brody (Ed.), Behavior in new 
environments. Beverly Hills, California: Sage.
Sarbin, T. R., & Mancuso, J. C. (19 80). Schizophrenia:
Medical diagnosis or moral verdict. New York: Pergamon 
Press.
Scheerenberger, R. C. (1983). A history of mental
retardation. Baltimore: Brooks Publishing Company.
Schopler, E., Reichler, R. J., & Renner, B. R. (1988). The 
Childhood Autism Rating Scale. Los Angeles: Western 
Psychological Services.
Senatore, V. , Matson, J. L., & Kazdin, A. E. (1985). An 
inventory to assess psychopathology of mentally 
retarded adults. American Journal of Mental 
Deficiency. 89., 459-466.
Shimkunas, A. M. (19 72) . Demand for intimate
self-disclosure and pathological verbalizations in 
schizophrenia. Journal of Abnormal Psychology. 80. 
197-205.
Sobel, D. E. (1961). Infant mortality and malformations in 
children of schizophrenic women. Psychiatric 
Quarterly. 35., 60-65.
Sparrow, S. S., Balia, D. A., & Cicchetti, D. V. (1984).
The Vindeland Adaptive Behavior Scales. Circle Pines, 
MN: American Guidance Service.
Spitzer, R. L., Endicott, J., & Robins, E. (1975). Research 
diagnostic criteria. New York: Biometric Research 
Unit, New York State Department of Mental Hygiene.
Stein, L., & Wise, C. D. (1971). Possible etiology of
schizophrenia: Progressive damage to the noradrenergic 
reward system by 6-hydroxydopamine. Science. 171. 
1032-1036.
Sturmey, P., & Ley, T. (1990). The psychopathology
instrument for mentally retarded adults: Internal 
consistencies and relationship to behaviour problems. 
British Journal of Psychiatry. 156. 428-430.
85
Tabachnik, B. G., & Fidell, L. S. (1983). Using
Multivariate Statistics. New York: Harper & Row, 
Publishers.
Torrey, E. F. (1979). Epidemiology. In L. Beliak (Ed.), 
Disorders of the schizophrenic syndrome. New York: 
Basic Books.
Turner, T. H. (1989). Schizophrenia and mental handicap: An 
historical review, with implications for further 
research. Psychological Medicine. 19, 301-314.
Webster, N. (1977) . Webster's New Twentieth Century
Dictionary of the English Language. Unabridged (2nd 
ed.). USA: William Collins & World Publishing Co.,
Inc.
Wilkinson, L. (1990) . Systat: The system for statistics. 
Evanston, IL: Systat, Inc.
Wing, L. (1980). The MRC handicaps, behaviour & skills 
(HBS) schedule. In E. Stromgren, A. Dupont, J. A. 
Nielson (Eds.), Epidemiological research as basis for 
the organization of extramural psychiatry. Acta 
Psychiatrica Scandinavica. Supplement 285. 241-247.
Wing, J. K., & Nixon, J. (1975). Discriminating symptoms in 
schizophrenia. Archives of General Psychiatry. 30, 
853-859 .
Wright, E. C. (1982) . The presentation of mental illness in 
mentally retarded adults. British Journal of 
Psychiatry. 141. 496-502.
Zigler, E., Balia, D., & Hodapp, R. (1984). On the
definition and classification of mental retardation. 
American Journal of Mental Deficiency. 89. 215-230.
Zubin, J., & Spring, B. J. (1977). Vulnerability: A new






A. Presence of either (l), (2), or (3) for at 
least one week (unless the symptoms are 
successfully treated):
(1) two of the following:
(a) delusions
(b) prominent hallucinations
(c) incoherence or marked loosening 
of associations
(d) catatonic behavior




B. During the course of the disturbance, 
functioning in such areas as work, social 
relations, and self-care is markedly below 
the highest level achieved before onset of 
the disturbance.
C. Schizoaffective Disorder and Mood Disorder 
with Psychotic Features have been ruled 
out.
D. Continuous signs of the disturbance for at 
least six months. The six-month period must 
include an active phase during which there 
were psychotic symptoms characteristic of 
Schizophrenia (symptoms in A), with or 
without a prodromal or residual phase. 
Prodromal phase: A clear deterioration in 
functioning before the active phase of the 
disturbance that is not due to a disturbance 
in mood or to a Psychoactive Substance Use 
Disorder and that involves at least two of 
the symptoms listed below.
Residual phase: Following the active phase
of the disturbance, persistence of at least 
two of the symptoms noted below, these not 
being due to a disturbance in mood or to a 
Psychoactive Substance Use Disorder. 
Prodromal or Residual symptoms:
(1) marked social isolation or withdrawal
(2) marked impairment in role functioning 
as wage-earner, student, or homemaker
(3) markedly peculiar behavior
(4) marked impairment in personal hygiene 
and grooming
(5) blunted or inappropriate affect
(6) digressive, vague, overelaborate, or 
circumstantial speech, or poverty of
88
speech, or poverty of content of speech
(7) odd beliefs or magical thinking, 
influencing behavior and inconsistent 
with cultural norms
(8) unusual perceptual experiences
(9) marked lack of initiative, interests, 
or energy
E. It cannot be established that an organic 
factor initiated and maintained the 
disturbance.
F. If there is a history of Autistic Disorder, 
the additional diagnosis of Schizophrenia 
is made only if prominent delusions or 
hallucinations are also present.
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25. unusual weight loss 
30. sadness







27. discomfort over anatomy
29. preoccupation with opposite sex



















7. frequently imagines illness
20. reports many aches and pains
22. reports illness to avoid work
24. imagines debilitating illness
33. preoccupation with illness
46. uses physical complaints to gain attention











2. adjusts to new situations
9. conforms to rules
36. pleasant to be around
44. refrains from inappropriate reports of illness
49. outgoing
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On the scale below, please indicate the degree to which the 
client in question has responded to medication.










1 . depressed mood 78.13 65.82 .36
2 . diminished interest 
or pleasure
81.25 60.94 . 52
3 . weight loss/gain 81.25 75.78 .23
4 . insomnia/hypersomnia 90.63 82 . 81 .46
5 . psychomotor agitation 
or retardation
76.56 68 .46 .26
6. fatigue or loss of 
energy
81.25 66.85 .43
7 . feelings of worthlessness 
or guilt
81.25 73 . 63 .29
8 . problems thinking, 
concentrating, and making 
decisions
76.56 63.28 .36
9 . recurrent thoughts of 
death, suicidal ideation, 
attempt, or plan
90.63 • 85.40 .36
10 . not initiated or maintained 
by organicity
73 .44 52 .44 .44
11. not normal reactions to 
death
75 . 00 52 .34 .48
12 . delusions/hallucinations 
not present two weeks 
without mood symptoms
82.81 50.59 .65
13. not diagnosed with psychosis 
D-Checklist
79 .69 50.00 .59
1 . depressed mood 76.19 68.08 .25
2a. poor appetite/overeating 78.69 71.49 .25
2b. insomnia/hypersomnia 83 . 61 74.36 .36
2c. low energy/fatigue 73 . 77 59 .31 .36
2d. low self-esteem 70 .49 57.92 .30
2e. poor concentration or 
difficulty making 
decisions
63 .93 56.63 . 17
2f. feelings of hopelessness 78.69 61.97 .44
3 . never without #1 > two 
months
75 . 81 62.38 .36
4. no signs of Major Depression 
first two years
77. 78 50.27 .55
5. Major Depression remitted 
six months prior
88.89 . 84.05 .30
6 . no history mania/hypomania 71. 88 54 . 88 .38
7. not currently diagnosed with 
psychosis or is relatively 
brief
84.38 50 . 00 .69
8. not initiated/maintained by 
organicity
84 .38 52 .34 .67
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S-Checklist
1. Delusions 85 .94 65 . 72
2 . prominent hallucinations 87.50 80 . 32
3 . incoherence, marked 
loosening associations
73 .44 63 .18
4 . catatonia 92 .19 89 .55
5 . flat/inappropriate affect 68.75 62 .31
6 . bizarre delusions 84.38 77.34
7. prominent auditory 
hallucinations
82 .81 79.00
8. continuous signs six months 82 .26 69.67
8a. social isolation/withdrawal 76.19 68 . 08
8b. impairment in role 
functioning
68.25 70.98
8c. peculiar behavior 76 .19 68.18
8d. impairment in hygiene/ 
grooming
73 . 02 76 . 04
8e. blunted/inappropriate affect 73.02 71.91
8f. speech excesses/deficits 77.78 77. 02
8g. odd beliefs/magical thinking 84.13 84 .93
8h. unusual perceptual 
experiences
85 . 71 86.62
8i. lack of initiative, 
interests, energy
74.60 62 .11
9 . functioning below potential 75 . 00 62 .31
10. Schizoaffective D/0 or Mood 
D/0 with psychosis ruled out
71.88 49.61
11. no history of Autistic D/O 75 . 00 60.94































6. flat affect 80.00 62.50 .47
8 . incoherent speech 95.00 65 . 00 . 86
11. auditory hallucinations 84 .21 63 . 71 .57
31. deterioration 85.00 71.00 .48
35 . delusions 90 . 00 68.00 .69
38 . withdrawal 80 . 00 62.50 .47
56. peculiar behavior 85.00 51.00 .69
Affective Disorder
15 . mood swings 80.00 49.50 . 60
21. decreased energy 85.00 65.00 . 57
25. unusual weght loss 85.00 78 . 00 .32
30 . sadness 70.00 52.00 .38
47. death wishes or crying 75.00 65.00 .29
50 . social withdrawal 80.00 62.00 .47
54. insomnia 95.00 86.00 .64
Psychosexual Disorder
10. sexual assaults 95.00 86.00 . 64
14. fetish 100.00 90.50 1.00
17. cross -dressing . . .
27. discomfort over anatomy . . •
29 . preoccupation opposite • • •
sex
34. desire to change sex 90.00 90.50 - .05
43 . exposes him/herself 100.00 90.50 1.00
Adiustment Disorder
16. noncompliant 80.00 72 .50 .27
19 . cannot cope with stress 65.00 48.00 .33
32 . hostile 75.00 65.00 .29
39 . nervous 75.00 52.00 .48
41. not responsible 85.00 70.00 .50
45. stealing 75.00 60.00 .38
48. antisocial 80.00 68.00 .38
Anxiety Disorder
3 . self-consciousness 70.00 50.00 .40
5 . anxiety 75.00 51.00 .49
26. cannot relax 85.00 65 . 00 .57
37. easily frustrated 75.00 55.00 .44
40. constant worry 60.00 57.50 .06
53 . shy 85.00 65.00 .57
55. difficulty concentrating 85 . 00 56.00 .66
Somatoform Disorder




20 . reports many aches and 
pains
70.00 68.00 .06
22. reports illness to avoid 
work
75 . 00 65 . 00 .29
24. imagines debilitating 
illness
• •
33 . preoccupation with 
illness
85.00 86 . 00 - .07
46. uses physical complaints 
to gain attention
80.00 62 .50 .47
51. frequent complaints of 
breathing problems ° •
Personality Disorder
4. emotionally cold 75.00 65 . 00 .29
12 . indifferent 80.00 68.00 .38
13 . demanding 80.00 62 .50 .47
18. excessive dependence 80.00 72 .50 .27
23 . odd speech 80.00 51.50 .59
28. suspicious 75 . 00 65.00 .29
42. self-dramatic 85.00 59 . 00 .63
Inappropriate Adjustment
1. appropriate affect 60.00 62 .50 - .07
2 . adjusts to new situations 70.00 50.00 .40
9 . conforms to new rules 90.00 58.00 . 76
36. pleasant to be around 75.00 65.00 .29
44. refrains from 
inappropriate reports of 
illness
73 .68 63 .71 .28
49 . outgoing 85.00 ■ 55.00 .67
52. no sexual hangups 65.00 56.00 .21
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